the-a1-adrenergic-receptor-antagonist-prazosinreduces-alcohol-drinking-in-alcohol-preferring-p-rats  < Prazosin in alcohol abuse disorders




potential-medications-for-the-treatment-of-alcohol-use-disorders  <<<EXCELLENT REVIEW

Amphetamine Addiction Treatment

A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.

Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings [Internet].

The role of gabapentin in the management of alcohol withdrawal and dependence.

Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment.

Gabapentin Therapy in Psychiatric Disorders_ A Systematic Review

The Effects of Carbamazepine and Lorazepam on Single versus Multiple Previous Alcohol Withdrawals in an Outpatient Randomized Trial

Alcohol Withdrawal Syndrome Benzodiazepines and Beyond


Gabapentin – Abuse, Dependence, and Withdrawal.

JAMA. 1986 Sep 19;256(11):1449-55. Disulfuram in the treatment of alcoholism: Abstract:

We conducted a controlled, blinded, multicenter study of disulfiram treatment of alcoholism in 605 men randomly assigned to 250 mg of disulfiram (202 men); 1 mg of disulfiram (204 men), a control for the threat of the disulfiram-ethanol reaction; or no disulfiram (199 men), a control for the counseling that all received. Bimonthly treatment assessments were done for one year. Relative/friend interviews and blood and urine ethanol analyses were used to corroborate patients’ reports. There were no significant differences among the groups in total abstinence, time to first drink, employment, or social stability. Among the patients who drank and had a complete set of assessment interviews, those in the 250-mg disulfiram group reported significantly fewer drinking days (49.0 +/- 8.4) than those in the 1-mg (75.4 +/- 11.9) or the no-disulfiram (86.5 +/- 13.6) groups. There was a significant relationship between adherence to drug regimen and complete abstinence in all groups. We conclude that disulfiram may help reduce drinking frequency after relapse, but does not enhance counseling in aiding alcoholic patients to sustain continuous abstinence or delay the resumption of drinking.

Why is disulfiram superior to acamprosate in the routine clinical setting A retrospective long-term study in 353 alcohol-dependent patients.

The Efficacy of Disulfiram for the Treatment of Alcohol Use Disorder

Acamprosate for treatment of alcohol dependence mechanisms, efficacy, and clinical utility

Transcranial Magnetic Stimulation and Deep Brain Stimulation in the treatment of alcohol dependence

Deep Brain Stimulation Expanding Applications.

Making Waves in the Brain What Are Oscillations, and Why Modulating Them Makes Sense for Brain Injury

Brain Stimulation in Addiction. NATURE 2016

Modulating Morphine Context-Induced Drug Memory With Deep Brain Stimulation More Research Questions by Lowering Stimulation Frequencies

The neurocircuitry involved in oxytocin modulation of methamphetamine addiction

Safety and efficacy of acamprosate for the treatment of alcohol dependence.

The dopamine system and alcohol dependence

Clinical effectiveness of baclofen for the treatment of alcohol dependence a review.

Pharmacotherapy for Alcohol Use Disorder Current and Emerging Therapies

Correlates of Baclofen Effectiveness in Alcohol Dependence

Injectable extended-release naltrexone for opioid dependence a double-blind, placebo-controlled

Injectable, sustained-release naltrexone for the treatment of opioid dependence a randomized, placebo-controlled trial.

Meta-Analysis of the Efficacy of rTMS in Psychiatric Disorders

The Efficacy of Disulfiram for the Treatment of Alcohol Use Disorder

A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder.

Sodium oxybate in the treatment of alcohol dependence from the alcohol withdrawal syndrome to the alcohol relapse prevention

Current pharmacological treatment approaches for alcohol dependence

Sodium Oxybate A Review of Its Use in Alcohol Withdrawal Syndrome and in the Maintenance of Abstinence in Alcohol Dependence

The Management of Alcohol Use Disorders_ The Impact of Pharmacologic, Affective, Behavioral, and Cognitive Approaches

Multi-Organ Alcohol-Related Damage Mechanisms and Treatment

Multidisciplinary View of Alcohol Use Disorder From a Psychiatric Illness to a Major Liver Disease

Citalopram Combined with Behavioral Therapy Reduces Cocaine Use A Double-Blind, Placebo-Controlled Trial

Gamma-Hydroxybutyrate Reduces both Withdrawal Syndrome and Hypercortisolism in Severe Abstinent Alcoholics

Vortioxetine a New Treatment for Major Depressive Disorder

New advances in the treatment of generalized anxiety disorder the multimodal antidepressant vortioxetine

Aripiprazole for relapse prevention and craving in alcohol use disorder current evidence and future perspectives

Potential medications for the treatment of alcohol use disorder

Risk versus risk a review of benzodiazepine reduction in older adults

Pharmacotherapy for alcohol dependence status of current treatments 2012

Effectiveness of Acamprosate in the Treatment of Alcohol Dependence

The Management of Alcohol Use Disorders_ The Impact of Pharmacologic, Affective, Behavioral, and Cognitive Approaches

Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs

Treatment of crack-cocaine dependence with topiramate A randomized controlled feasibility trial

Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on herpom assisted treatment

Emerging pharmacotherapies for alcohol dependence A systematic review focusing on reduction

Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders

The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system

Baclofen as Add-On to Standard Psychosocial Treatment for Alcohol Dependence a Randomized

Assessment and treatment of insomnia in adult patients with alcohol use disorders

Pharmacotherapy for alcohol dependence status of current treatments 2012

Multi-Organ Alcohol-Related Damage Mechanisms and Treatment

The Management of Alcohol Use Disorders_ The Impact of Pharmacologic, Affective, Behavioral, and Cognitive Approaches

Multidisciplinary View of Alcohol Use Disorder From a Psychiatric Illness to a Major Liver Disease

Citalopram Combined with Behavioral Therapy Reduces Cocaine Use A Double-Blind, Placebo-Controlled Trial

Baclofen as Add-On to Standard Psychosocial Treatment for Alcohol Dependence a Randomized

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence a randomized controlled trial.

Efficacy of Extended-Release Naltrexone in Patients with Relatively Higher Severity of Alcohol Dependence

The Status of Naltrexone in the Treatment of Alcohol Dependence Specific Effects on Heavy Drinking

The COMBINE Study— for treatment of alcohol

The Management of Alcohol Use Disorders_ The Impact of Pharmacologic, Affective, Behavioral, and Cognitive Approaches b

Pharmacotherapy for Alcohol Use Disorders Physicians’ Perceptions

Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence


























Alcohol-Use Disorders: Diagnosis, Assessment and Management of Harmful Drinking and Alcohol Dependence.

  • Adamson SJ, Sellman JD. Five-year outcomes of alcohol-dependent persons treated with motivational enhancement. Journal of Studies on Alcohol and Drugs. 2008;69:589–593. [PubMed]
  • Adamson SJ, Sellman JD, Frampton CM. Patient predictors of alcohol treatment outcome: a systematic review. Journal of Substance Abuse Treatment. 2009;36:75–86. [PubMed]
  • Adamson SJ, Heather N, Morton V, et al. Initial preference for drinking goal in the treatment of alcohol problems: II. Treatment outcomes. Alcohol and Alcoholism. 2010;45:136–142. [PubMed]
  • Addolorato G, Leggio L, Ferrulli A, et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. The Lancet. 2007;370:1915–1922. [PubMed]
  • Addolorato G, Leggio L, Ojetti V, et al. Effects of short-term moderate alcohol administration on oxidative stress and nutritional status in healthy males. Appetite. 2008;50:50–56. [PubMed]
  • Adelstein AM, Marmot MG, Bulusu L. Migrant studies in Britatin. British Medical Bulletin. 1984;40:315–319. [PubMed]
  • Agrawal A, Hinrichs AL, Dunn G, et al. Linkage scan for quantitative traits identifies new regions of interest for substance dependence in the Collaborative Study on the Genetics of Alcoholism (COGA) sample. Drug and Alcohol Dependence. 2008;93:12–20. [PMC free article] [PubMed]
  • AGREE Collaboration. Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument. London: St George’s Hospital Medical School; 2001.
  • AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Quality and Safety in Health Care. 2003;12:18–23. [PMC free article] [PubMed]
  • Ahles TA, Schlundt DG, Prue DM, et al. Impact of aftercare arrangements on the maintenance of treatment success in abusive drinkers. Addictive Behaviors. 1983;8:53–58. [PubMed]
  • Ahmadi J, Ahmadi N. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence. German Journal of Psychiatry. 2002;5:85–89.
  • Ahn H, Wampold B. Where oh where are the specific ingredients? A metaanalysis of component studies in counseling and psychotherapy. Journal of Counseling Psychology. 2001;48:251–257.
  • Aira M, Kauhanen J, Larivaara P, et al. Factors influencing inquiry about patients’ alcohol consumption by primary health care physicians: qualitative semi-structured interview study. Family Practice. 2003;20:270–275. [PubMed]
  • Alcoholics Anonymous. About Us: Membership. 2010. [May 2011]. Available from: http://www​.alcoholics-anonymous​
  • Alden LE. Behavioral self-management controlled-drinking strategies in a context of secondary prevention. Journal of Consulting and Clinical Psychology. 1988;56:280–286. [PubMed]
  • Alessi SM, Hanson T, Wieners M, et al. Low-cost contingency management in community clinics: delivering incentives partially in group therapy. Experimental and Clinical Psychopharmacology. 2007;15:293–300. [PubMed]
  • Alexander L. Wernicke’s disease. Identity of lesions produced experimentally by B1 avitaminosis in pigeons with hemorhaggic polioencephalitis occurring in chronic alcoholism in man. American Journal of Pathology. 1940;16:61–70. [PMC free article] [PubMed]
  • Alexander JF, Waldron HB, Newberry A, et al. The functional family therapy model, Family Therapy for Adolescent Drug Abuse. Friedman AS, Granick S, editors. Lexington, MA: Lexington Books; 1990. pp. 183–200.
  • Allan C, Smith I, Mellin M. Detoxification from alcohol: a comparison of home detoxification and hospital-based day patient care. Alcohol and Alcoholism. 2000;35:66–69. [PubMed]
  • Allen J, Copello A, Orford J. Fear during alcohol detoxification: views from the clients’ perspective. Journal of Health Psychology. 2005;10:503–510. [PubMed]
  • Allen JP. Assessment of alcohol problems: an overview, Assessing Alcohol Problems: A Guide for Clinicians and Researchers. Allen JP, Wilson WB, editors. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2003.
  • Allen JP, Wilson VB. Assessing Alcohol Problems: A Guide for Clinicians and Researchers. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2003.
  • Allen JP, Sillanaukee P, Strid N, et al. Assessing Alcohol Problems: A Guide for Clinicians and Researchers. Allen JP, Wilson VB, editors. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2003.
  • Allen NB, Chambers R, Knight W. Mindfulness-based psychotherapies: a review of conceptual foundations, empirical evidence and practical considerations. Australian and New Zealand Journal of Psychiatry. 2006;40:285–294. [PubMed]
  • Alterman A, Hayashida M, O’Brien CP. Treatment response and safety of ambulatory medical detoxification. Journal of Studies on Alcohol. 1988;49:160–166. [PubMed]
  • Altintoprak AE, Zorlu N, Coskunol H, et al. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study. Human Psychopharmacology: Clinical and Experimental. 2008;23:313–319. [PubMed]
  • Altman DG, Bland JM. Diagnostic tests 1: sensitivity and specificity. British Medical Journal. 1994;308:1552. [PMC free article] [PubMed]
  • Altman DG, Bland JM. Diagnostic tests 2: predictive values. British Medical Journal. 1994;309:102. [PMC free article] [PubMed]
  • Alwyn T, John B, Hodgson RJ, et al. The addition of a psychological intervention to a home detoxification programme. Alcohol and Alcoholism. 2004;39:536–541. [PubMed]
  • American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with substance use disorders. Journal of the American Academy of Child and Adolescent Psychiatry. 2005;44:609–621. [PubMed]
  • Anderson DA, Parker JD. The use of a mental status examination in a chemical dependence treatment program. Journal of Substance Abuse Treatment. 1997;14:377–382. [PubMed]
  • Anderson P, Baumberg B. Alcohol in Europe A Report for the European Commission. London: Institute of Alcohol Studies; 2005.
  • Andreasson S, Hansagi H, Österlund B. Short-term treatment for alcohol-related problems: four session guided self change versus one session of advice – a randomized, controlled trial. Addiction. 2002;28:57–62. [PubMed]
  • Annemans L, Vanoverbeke N, Tecco J, et al. Economic evaluation of Campral (Acamprosate) compared to placebo in maintaining abstinence in alcohol-dependent patients. European Addiction Research. 2000;6:71–78. [PubMed]
  • Annis HA. A relapse prevention model for treatment of alcoholics, Treating Addictive Behaviors Processes of Change. Miller WR, Heather N, editors. New York: Plenum Press; 1986.
  • Annis HM. Inpatient versus outpatient setting effects in alcoholism treatment: revisiting the evidence. Addiction. 1996;91:1804–1807.
  • Anton RF. Naltrexone for the management of alcohol dependence. New England Journal of Medicine. 2008;359:715–721. [PMC free article] [PubMed]
  • Anton RF, Moak DH. Carbohydrate deficient transferrin (CDT) and gamma-glutamyl transferase (GGT) as markers of heavy alcohol consumption: gender differences. Alcoholism: Clinical and Experimental Research. 1994;18:747–754. [PubMed]
  • Anton RF, Moak DH, Waid LR, et al. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo controlled trial. American Journal of Psychiatry. 1999;156:1758–1764. [PubMed]
  • Anton RF, Pettinati H, Zweben A, et al. A multi-site dose ranging study of Nalmefene in the treatment of alcohol dependence. Journal of Clinical Psychopharmacology. 2004;24:421–428. [PubMed]
  • Anton RF, Moak DH, Latham P, et al. Naltrexone combined with either cognitive behavioural or motivational enhancement therapy for alcohol dependence. Journal of Clinical Psychopharmacology. 2005;25:349–357. [PubMed]
  • Anton RF, O’Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence. The Journal of the American Medical Association. 2006;295:2003–2017. [PubMed]
  • Anton RF, Kranzler H, Breder C, et al. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence. Journal of Clinical Psychopharmacology. 2008;28:5–12. [PubMed]
  • Anton RF, Oroszi G, O’Malley S, et al. An evaluation of μ-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Archives of General Psychiatry. 2008;65:135–144. [PMC free article] [PubMed]
  • APA. Diagnostic and Statistical Manual of Mental Disorders, 3rd revised (DSM–III–R) Washington, DC: APA; 1987.
  • APA. Diagnostic and Statistical Manual of Mental Disorders, 4th revised (DSM-IV) Washington, DC: APA; 1994.
  • APA. DSM-5 Development: Substance-Related Disorders. Washington, DC: APA; 2010. [5 October 2010]. Available from: www​​/pages/substance–relateddisorders.aspx.
  • Army Individual Test Battery. Manual of Directions and Scoring. Washington, DC: War Department, Adjutant General’s Office; 1944.
  • Asplund CA, Aaronson JW, Aaronson HE. 3 regimens for alcohol withdrawal and detoxification. Journal of Family Practice. 2004;53:545–554. [PubMed]
  • Babor TF. Reliability of the ethanol dependence syndrome scale. Psychology of Addictive Behaviors. 1996;10:97–103.
  • Babor TF, Higgins-Biddle JC, Saunders JB, et al. AUDIT – The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care. 2. Geneva: WHO; 2001.
  • Babor TF, Steinberg K, Zweben A, et al. Treatment effects across multiple dimensions of outcome, Treatment Matching in Alcoholism. Babor TF, Del Boca FK, editors. Cambridge: Cambridge University Press; 2003. pp. 50–165.
  • Bacchus L. Client perceptions of inpatient treatment: a qualitative account with implications for service delivery. Drugs: Education, Prevention and Policy. 1999;6:87–97.
  • Back SE, Brady KT, Sonne SC, et al. Symptom improvement in co-occurring PTSD and alcohol dependence. The Journal of Nervous and Mental Disease. 2006;194:690–696. [PubMed]
  • Baekeland F, Lundwell L, Kissin B, et al. Correlates of outcome in disulfiram treatment of alcoholism. The Journal of Nervous and Mental Disease. 1971;153:1–9. [PubMed]
  • Bagrel A, d’Houtaud A, Gueguen R, et al. Relations between reported alcohol consumption and certain biological variables in an “unselected” population. Clinical Chemistry. 1979;25:1242–1246. [PubMed]
  • Bak T, Mioshi E. A cognitive bedside assessment beyond the MMSE: the Addenbrooke’s Cognitive Examination. Practical Neurology. 2007;7:245–249. [PubMed]
  • Balldin J, Berglund M, Borg S, et al. A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence. Alcoholism: Clinical and Experimental Research. 2003;27:1142–1149. [PubMed]
  • Baltieri DA, de Andrade AG. Efficacy of acamprosate in the treatment of alcohol-dependent outpatients. Revista Brasileira de Psiquiatria. 2003;25:156–159. [PubMed]
  • Baltieri DA, Daró FR, Ribeiro PL, et al. Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction. 2008;103:2035–2044. [PubMed]
  • Banys P. The clinical use of disulfiram (Antabuse): a review. Journal of Psychoactive Drugs. 1988;20:243–260. [PubMed]
  • Barber JP, Crits-Christoph P, Luborsky L. Effects of therapist adherence and competence on patient outcome in brief dynamic therapy. Journal of Consulting and Clinical Psychology. 1996;64:619–622. [PubMed]
  • Barber JP, Gallop R, Crits-Christoph P, et al. The role of therapist adherence, therapist competence, and the alliance in predicting outcome of individual drug counseling: Results from the NIDA Collaborative Cocaine Treatment Study. Psychotherapy Research. 2006;16:229–240.
  • Barnaby B, Drummond DC, McCloud A, et al. Substance misuse in psychiatric inpatients: comparison of a screening questionnaire survey with case notes. British Medical Journal. 2003;327:783–784. [PMC free article] [PubMed]
  • Barrias JA, Chabac S, Ferreira L, et al. Acamprosate: multicenter Portuguese efficacy and tolerance evaluation study. Psiquiatria Clinica. 1997;18:149–160.
  • Barry KL, Fleming MF. The Alcohol Use Disorders Identification Test (AUDIT) and the SMAST-13 predictive validity in a rural primary care sample. Alcohol. 1993;28:33–42. [PubMed]
  • Bart G, Schluger JH, Borg L, et al. Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa-opioid agonist activity? Neuropsychopharmacology. 2005;30:2254–2262. [PubMed]
  • Bartu A, Saunders W. Domiciliary detoxification: a cost effective alternative to inpatient treatment. Australian Journal of Advanced Nursing. 1994;11:12–18. [PubMed]
  • Bates ME, Barry D, Dowden SC. Neurocognitive impairment associated with alcohol use disorders: implications for treatment. Experimental and Clinical Psychopharmacology. 2002;10:193–212. [PubMed]
  • Beck AT, Wright FD, Newman CF. Cognitive Therapy of Substance Abuse. New York, NY: Guildford Press; 1993.
  • Beich A, Gannik D, Malterud K. Screening and brief intervention for excessive alcohol use: qualitative interview study of the experiences of general practitioners. British Medical Journal. 2002;325:870–874. [PMC free article] [PubMed]
  • Bell DC, Williams ML, Nelson R, et al. An experimental test of retention in residential and outpatient programs. American Journal of Drug and Alcohol Abuse. 1994;20:331–340. [PubMed]
  • Bennett-Levy J, Richards DA, Farrand P, editors. The Oxford Guide to Low Intensity CBT Interventions. Oxford: Oxford University Press; 2010.
  • Berglund M. A better widget? Three lessons for improving addiction treatment from a meta-analytical study. Addiction. 2005;100:742–750. [PubMed]
  • Berlin JA. Does blinding of readers affect the results of meta-analyses? Lancet. 2001;350:185–186. [PubMed]
  • Besson J, Aeby F, Kasas A, et al. Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study. Alcoholism: Clinical and Experimental Research. 1998;22:573–579. [PubMed]
  • Beullens J, Aertgeerts B. Screening for alcohol abuse and dependence in older people using DSM criteria: a review. Aging & Mental Health. 2004;8:76–82. [PubMed]
  • Bien TH, Miller WR, Tonigan JS. Brief interventions for alcohol problems: a review. Addiction. 1993;88:315–335. [PubMed]
  • Bischof G, Grothues J, Reinhardt S, et al. Evaluation of a telephone-based stepped care intervention for alcohol-related disorders: a randomised controlled trial. Drug and Alcohol Dependence. 2008;93:244–251. [PubMed]
  • Bischof GH, Richmond CJ, Case AR. Detoxification at home: a brief solution-oriented family systems approach. Contemporary Family Medicine. 2003;25:17–39.
  • Blondell RD. Ambulatory detoxification of patients with alcohol dependence. American Family Physician. 2005;71:495–502. [PubMed]
  • Blondell RD, Looney SW, Hottman LM, et al. Characteristics of intoxicated trauma patients. Journal of Addiction Disorders. 2002;21:1–12. [PubMed]
  • Boeijinga PH, Parot P, Soufflet L, et al. Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pre-treatment and during alcohol abstinence. Neuropsychobiology. 2004;50:71–77. [PubMed]
  • Boland B, Drummond DC, Kaner E. Brief interventions for alcohol use disorders. Advances in Psychiatric Treatment. 2008;14:469–476.
  • Bond GR, McDonel EC. Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychiatric Rehabilitation Journal. 1991;15:31–43.
  • Book SW, Thomas SE, Randall PK, et al. Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder. Journal of Anxiety Disorders. 2008;22:310–318. [PMC free article] [PubMed]
  • Booth BM, Blow FC. The kindling hypothesis: Further evidence from a U.S. national survey of alcoholic men. Alcohol and Alcoholism. 1993;28:593–598. [PubMed]
  • Booth BM, Ludke RL, Wakefield DS, et al. Nonacute inpatient admissions to department of veterans affairs medical centers. Medical Care. 1991;29(Suppl.):AS40–AS50.
  • Booth BM, Blow FC, Ludke RL, et al. Utilization of acute inpatient services for alcohol detoxification. The Journal of Mental Health Administration. 1996;23:366–374. [PubMed]
  • Bordin ES. The generalizability of the psychoanalytic concept of the working alliance. Psychotherapy: Theory, Research & Practice. 1979;16:252–260.
  • Bostwick JM, Lapid MI. False positives on the Clinical Institute Withdrawal Assessment for Alcohol – Revised: is this scale appropriate for use in the medically ill? Psychosomatics. 2004;45:256–261. [PubMed]
  • Bowden SC. Separating cognitive impairment in neurologically asymptomatic alcoholism from Wernicke-Korsakoff syndrome: is the neuropsychological distinction justified? Psychological Bulletin. 1990;107:355–366. [PubMed]
  • Bowen RC, D’Arcya CA, Keegana D. A controlled trial of cognitive behavioral treatment of panic in alcoholic inpatients with comorbid panic disorder. Addictive Behaviors. 2000;25:593–597. [PubMed]
  • Bowen S, Witkiewitz K, Dillworth TM, et al. Mindfulness meditation and substance use in an incarcerated population. Psychology of Addictive Behaviors. 2006;20:343–347. [PubMed]
  • Bowen S, Witkiewitz K, Dillworth TM, et al. The role of thought suppression in the relationship between mindfulness meditation and alcohol use. Addictive Behaviors. 2007;32:2324–2338. [PMC free article] [PubMed]
  • Bower P, Gilbody S. Stepped care in psychological therapies: access, effectiveness and efficiency. Narrative literature review. British Journal of Psychiatry. 2005;186:11–17. [PubMed]
  • Bradizza CM, Stasiewicz PR, Paas ND. Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: A review. Clinical Psychology Review. 2006;26:162–178. [PubMed]
  • Brady KT, Myrick H, Henderson S, et al. The use of divalproex in alcohol relapse prevention: a pilot study. Drug and Alcohol Dependence. 2002;67:323–330. [PubMed]
  • Brady KT, Sonne S, Anton RF, et al. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcoholism: Clinical and Experimental Research. 2005;29:395–401. [PubMed]
  • Branchey L, Davis W, Lee KK, et al. Psychiatric complications of disulfiram treatment. The American Journal of Psychiatry. 1987;144:1310–1312. [PubMed]
  • Brayne C, Best N, Muir M, et al. Five-year incidence and prediction of dementia and cognitive decline in a population sample of women aged 70–79 at baseline. International Journal of Geriatric Psychiatry. 1997;12:1107–1118. [PubMed]
  • Breslin FC, Sobell M, Sobell L, et al. Toward a stepped care approach to treating problem drinkers: The predictive utility of within-treatment variables and therapist prognostic ratings. Addiction. 1997;92:1479–1489. [PubMed]
  • Breslin FC, Sobell M, Sobell L, et al. Problem drinkers: evaluation of a stepped-care approach. Journal of Substance Abuse. 1999;10:217–232. [PubMed]
  • Brewer C. How effective is the standard dose of disulfiram? A review of the alcohol-disulfiram reaction in practice. The British Journal of Psychiatry. 1984;144:200–202. [PubMed]
  • British Association of Counselling. Code of Ethics and Practice for Counsellors. Rugby: BAC; 1992.
  • British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary, 59th edition (BNF 59) London: British Medical Association and the Royal Pharmaceutical Society of Great Britain; 2010.
  • Brosan L, Moore R, Reynolds S. Factors associated with competence in cognitive therapists. Behavioural and Cognitive Psychotherapy. 2007;35:179–190.
  • Brotman MA, Strunk DR, DeRubeis RJ. Therapeutic Alliance and Adherence in Cognitive Therapy for Depression. 2009. In preparation.
  • Brower KJ. Insomnia, alcoholism and relapse. Sleep Medicine Reviews. 2003;7:523–539. [PubMed]
  • Brower KJ, Myra Kim H, Strobbe S, et al. A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia. Alcoholism: Clinical & Experimental Research. 2008;32:1429–1438. [PMC free article] [PubMed]
  • Brown JD. Testing in Language Programs. Upper Saddle River, NJ: Prentice Hall Regents; 1996. pp. 231–294.
  • Brown ME, Anton RF, Malcolm R, et al. Alcohol detoxification and withdrawal seizures: clinical support for kindling hypothesis. Biological Psychiatry. 1988;23:507–514. [PubMed]
  • Brown S, McGue M, Maggs J, et al. A developmental perspective on alcohol and youths 16 to 20 years of age. Pediatrics. 2008;121(Suppl. 4):S290–S310. [PMC free article] [PubMed]
  • Brown SA, Inaba RK, Gillin JC, et al. Alcoholism and affective disorder: clinical course of depressive symptoms. American Journal of Psychiatry. 1995;152:45–52. [PubMed]
  • Brown SA, Meyer MG, Lippke L, et al. Psychometric evaluation of the customary drinking and drug use record (CDDR): a measure of adolescent alcohol and drug involvement. Journal of Studies on Alcohol. 1998;59:427–438. [PubMed]
  • Brown TG, Seraganian P, Tremblay J, et al. Process and outcome changes with relapse prevention versus 12-step aftercare programs for substance abusers. Addiction. 2002;97:677–689. [PubMed]
  • Bryant MJ, Simons AD, Thase ME. Therapist skill and patient variables in homework compliance: controlling an uncontrolled variable in cognitive therapy outcome research. Cognitive Therapy and Research. 1999;23:381–399.
  • Bucholz KK, Cadoret R, Cloninger CR, et al. Semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability for the SSAGA. Journal of Studies on Alcohol. 1994;55:149–158. [PubMed]
  • Bullock M, Umen A, Culliton P, et al. Acupuncture treatment of alcoholic recidivism: a pilot study. Alcoholism: Clinical and Experimental Research. 1987;11:292–295. [PubMed]
  • Bullock M, Culliton P, Olander R. Controlled trial of acupuncture for severe recidivist alcoholism. Lancet. 1989;1(June):1435–1439. [PubMed]
  • Bullock ML, Kiresuk TJ, Sherman RE, et al. A large randomized placebo controlled study of auricular acupuncture for alcohol dependence. Journal of Substance Abuse Treatment. 2002;22:71–77. [PubMed]
  • Burman S. The challenge of sobriety: natural recovery without treatment and self-help groups. Journal of Substance Abuse. 1997;9:41–61. [PubMed]
  • Burns DD, Nolen-Hoeksema S. Therapeutic empathy and homework compliance in cognitive-behavioral therapy. Journal of Consulting and Clinical Psychology. 1992;60:441–449. [PubMed]
  • Burtscheidt W, Wolwer W, Schwarz R, et al. Out-patient behaviour therapy in alcoholism: treatment outcome after 2 years. Acta Psychiatrica Scandinavica. 2001;106:227–232. [PubMed]
  • Burtscheidt W, Wolwer W, Schwarz R, et al. Out-patient behaviour therapy in alcoholism: treatment outcome after 2 years. Acta Psychiatrica Scandinavica. 2002;106:227–232. [PubMed]
  • Bush K, Kivlahan DR, McDonell MB, et al. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Archives of Internal Medicine. 1998;158:1789–1795. [PubMed]
  • Busto U, Simpkins J, Sellers EM, et al. Objective determination of benzodiazepine use and abuse in alcoholics. British Journal of Addiction. 1983;78:429–435. [PubMed]
  • Butterworth RF. Effects of thiamine deficiency on brain metabolism: implications for the pathogenesis of the Wernicke-Korsakoff syndrome. Alcohol and Alcoholism. 1989;24:271–279. [PubMed]
  • Cahill J, Barkham M, Hardy G, et al. Outcomes of patients completing and not completing cognitive therapy for depression. British Journal of Clinical Psychology. 2003;42:133–143. [PubMed]
  • Campbell NC, Murray E, Darbyshire J, et al. Desigining and evaluating complex interventions to improve health care. British Medical Journal. 2007;334:455–459. [PMC free article] [PubMed]
  • Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. British Medical Journal. 2005;331:897–900. [PMC free article] [PubMed]
  • Carroll KM, Rounsaville BJ, Bryant KJ. Alcoholism in treatment seeking cocaine abusers: Clinical and prognostic significance. Journal of Studies on Alcohol. 1993;54:199–208. [PubMed]
  • Carroll K, Nich C, Ball S, et al. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction. 1998;93:713–728. [PubMed]
  • Carroll K, Nich C, Ball S, et al. One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment. Addiction. 2000;95:1335–1349. [PubMed]
  • Carroll KM, Fenton LR, Ball SA, et al. Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Archives of General Psychiatry. 2004;61:264–272. [PMC free article] [PubMed]
  • Casswell S, Thamarangsi T. Reducing harm from alcohol: call to action. The Lancet. 2009;373:2247–2257. [PubMed]
  • Chapman PLH, Huygens I. An evaluation of three treatment programmes for alcoholism: an experimental study with 6- and 18-month follow-ups. British Journal of Addiction. 1988;83:67–81. [PubMed]
  • Charney AA, Paraherakis AM, Gill KJ. Integrated treatment of comorbid depression and substance use disorders. Journal of Clinical Psychiatry. 2001;62:672–677. [PubMed]
  • Cheeta S, Drummond C, Oyefeso A, et al. Low identification of alcohol use disorders in general practice in England. Addiction. 2008;103:766–773. [PubMed]
  • Chick J. Safety issues concerning the use of disulfiram in treating alcohol dependence. Drug Safety. 1999;20:427–435. [PubMed]
  • Chick J, Ritson B, Connaughton J, et al. Advice versus extended treatment for alcoholism: A controlled study. British Journal of Addiction. 1988;83:159–170. [PubMed]
  • Chick J, Gough K, Falkowski W, et al. Disulfiram treatment of alcoholism. British Journal of Psychiatry. 1992;161:84–89. [PubMed]
  • Chick J, Howlett H, Morgan MY, et al. United Kingdom multicentre acamprosate study (UKMAS): A 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alcohol and Alcoholism. 2000;35:176–187. [PubMed]
  • Chick J, Anton R, Checinski K, et al. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol and Alcoholism. 2000;35:587–593. [PubMed]
  • Chiesa A. Vipassana meditation: systermatic review of current evidence. Journal of Alternative and Complementary Medicine. 2010;16:37–46. [PubMed]
  • Cho SH, Wang WW. Acupuncture for alcohol dependence: a systematic review. Alcoholism: Clinical and Experimental Research. 2009;33:1305–1313. [PubMed]
  • Choudry N. Medical treatment for problem drug takers, Treating Drug Abusers. Bennett G, editor. London: Routledge; 1990.
  • Christiansen BA, Smith GT, Roehling PV, et al. Using alcohol expectancies to predict adolescent drinking behavior after one year. Journal of Consulting and Clinical Psychology. 1989;57:93–99. [PubMed]
  • Christo G, Spurrell S, Alcorn R. Validation of the Christo Inventory for Substance-misuse Services (CISS): a simple outcome evaluation tool. Drug and Alcohol Dependence. 2000;59:189–197. [PubMed]
  • Chung T, Colby N, Barnett D, et al. Screening adolescents for problem drinking and performance of brief screens against DSM–IV alcohol diagnoses. Journal of Studies on Alcohol. 2000;61:579–587. [PubMed]
  • Chung T, Martin CS, Winters KC, et al. Assessment of alcohol tolerance in adolescents. Journal of Studies on Alcohol. 2001;62:687–695. [PubMed]
  • Chutuape MA, Katz EC, Stitzer ML. Methods for enhancing transition of substance dependence patients from inpatient to outpatient treatment. Drug and Alcohol Dependence. 2001;61:137–143. [PubMed]
  • Cicerone KD, Dahlberg C, Malec JF, et al. Evidence-based cognitive rehabilitation: updated review of the literature from 1998 through 2002. Archives of Physical Medicine and Rehabilitation. 2005;86:1681–1692. [PubMed]
  • Ciraulo DA, Sands BF, Shader RI. Critical review of liability for benzodiazepine abuse among alcoholics. The American Journal of Psychiatry. 1988;145:1501–1506. [PubMed]
  • Clark DB, Lesnick L, Hegedus AM. Traumas and other adverse life events in adolescents with alcohol abuse and dependence. Journal of the American Academy of Child and Adolescent Psychiatry. 1997;36:1744–1751. [PubMed]
  • Clark DB, Pollock N, Bukstein OG, et al. Gender and comorbid psychopathology in adolescents with alcohol dependence. Journal of the American Academy of Child and Adolescent Psychiatry. 1997;36:1195–1203. [PubMed]
  • Clark DB, Lynch KG, Donovan JE, et al. Health problems in adolescents with alcohol use disorders: self-report, liver injury, and physical examination findings and correlates. Alcoholism: Clinical and Experimental Research. 2001;25:1350–1359. [PubMed]
  • Clark DB, De Bellis MD, Lynch KG, et al. Physical and sexual abuse, depression and alcohol use disorders in adolescents: onsets and outcomes. Drugs and Alcohol Dependence. 2003;69:51–60. [PubMed]
  • Clark DM, Layard R, Smithies R, et al. Improving access to psychological therapy: initial evaluation of two UK demonstration sites. Behaviour Research and Therapy. 2009;47:910–920. [PMC free article] [PubMed]
  • Cloninger CR, Bohman M, Sigvardsson S. Inheritance of alcohol abuse. cross-fostering analysis of adopted men. Archives of General Psychiatry. 1981;38:861–868. [PubMed]
  • Cochrane Collaboration. Review Manager (RevMan) [Computer program] Version 427 for Windows. Oxford: The Cochrane Collaboration; 2004.
  • Cochrane M, Cochrane A, Jauhar P, et al. Acetylcholinesterase inhibitors for the treatment of Wernicke-Korsakoff syndrome- three further cases show response to donepezil. Alcohol and Alcoholism. 2005;40:151–144. [PubMed]
  • Coffey T. The process of teaching alcohol and opiod withdrawal management strategies to nursing staff in a new medical center. Journal of Addictions Nursing. 1996;8:29–35.
  • Colby SM, Monti P, Barnett N, et al. Brief motivational interviewing in a hospital setting for adolescent smoking: a preliminary study. Journal of Consulting and Clinical Psychology. 1998;66:574–578. [PubMed]
  • Collins MN, Burns T, van den Berk PAH, et al. A structured programme for outpatient alcohol detoxification. British Journal of Psychiatry. 1990;156:871–874. [PubMed]
  • Connors G, Carroll K, DiClemente C, et al. The therapeutic alliance and its relationship to alcoholism treatment participation and outcome. Journal of Consulting and Clinical Psychology. 1997;65:588–598. [PubMed]
  • Connors GJ, Walitzer KS. Reducing alcohol consumption among heavily drinking women: evaluating the contributions of life-skills training and booster sessions. Journal of Consulting and Clinical Psychology. 2001;69:447–456. [PubMed]
  • Conrad KJ, Hultman CI, Pope AR, et al. Case managed residential care for homeless addicted veterans: results of a true experiment. Medical Care. 1998;36:40–53. [PubMed]
  • Conrod PJ, Stewart SH, Pihl RO, et al. Efficacy of brief coping skills interventions that match different personality profiles of female substance abusers. Psychology of Addictive Behaviours. 2000;14:231–242. [PubMed]
  • Cook CCH. Aetiology of alcohol misuse, Seminars in Alcohol and Drug Misuse. Chick J, Cantwell R, editors. London: Gaskell; 1994.
  • Cook CCH. Prevention and treatment of Wernicke-Korsakoff syndrome. Alcohol and Alcoholism. 2000;35(Suppl. 1):19–20. [PubMed]
  • Cook CCH, Hallwood PM, Thomson AD. B vitamin deficiency and neuropsychiatric syndromes in alcohol misuse. Alcohol and Alcoholism. 1998;33:317–336. [PubMed]
  • Cook P. Social costs of drinking. In: Assland OG, editor. Expert Meeting on the Negative Social Consequences of Alcohol Use; 27–31 August 1990; Oslo: Norwegian Ministry of Health and Social Affairs; 1990. pp. 49–94.
  • Cooney NL, Kadden RM, Litt MD, et al. Matching alcoholics to coping skills or interactional therapies: two year follow up results. Journal of Consulting and Clinical Psychology. 1991;59:598–601. [PubMed]
  • Cooper DB. Alcohol Dome detoxification and Assessment. Oxford: Radcliffe Medical Press; 1994.
  • Copeland J. A qualitative study of barriers to formal treatment among women who self-managed change in addictive behaviours. Journal of Substance Abuse Treatment. 1997;14:183–190. [PubMed]
  • Copello A, Orford J, Hodgson R, et al. Social behaviour and network therapy: basic principles and early experiences. Addictive Behavior. 2002;27:345–366. [PubMed]
  • Copello AG, Velleman RD, Templeton LJ. Family interventions in the treatment of alcohol and drug problems. Drug and Alcohol Review. 2005;24:369–385. [PubMed]
  • Copello AG, Templeton L, Velleman R. Family interventions for drug and alcohol misuse: is there a best practice? Current Opinion in Psychiatry. 2006;19:271–276. [PubMed]
  • Copello AG, Templeton L, Orford J, et al. The relative efficacy of two levels of a primary care intervention for family members affected by the addiction problem of a close relative: a randomized trial. Addiction. 2009;104:49–58. [PubMed]
  • Cornelius JR, Salloum IM, Thase ME, et al. Fluoxetine versus placebo in depressed alcoholic cocaine abusers. Psychopharmacology Bulletin. 1998;34:117–121. [PubMed]
  • Coulthard M, Farrell M, Singleton N, Meltzer H. Tobacco, Alcohol and Drug Use and Mental Health. The Office for National Statistics, London: The Stationary Office; 2002.
  • Coulton S, Drummond C, James D, et al. Opportunistic screening for alcohol use disorders in primary care: comparative study. British Medical Journal. 2006;332:511–517. [PMC free article] [PubMed]
  • Cousins MS, Roberts DC, de Wit H. GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings. Drug and Alcohol Dependence. 2002;65:209–220. [PubMed]
  • Cox GB, Walker DR, Freng SA, et al. Outcome of a controlled trial of the effectiveness of intensive case management for chronic public inebriates. Journal of Studies on Alcohol. 1998;59:523–532. [PubMed]
  • Cox WM, Klinger E, editors. Handbook of Motivational Counseling: Concepts, Approaches, and Assessment. New York, NY: John Wiley & Sons; 2004.
  • Craig R, Mindell J, Hirani V. Health Survey for England 2008. Volume 1: Physical Activity and Fitness. London: NHS Information Centre; 2009.
  • Crum RM, Anthony JC, Bassett SS, et al. Population-based norms for the Mini-Mental State Examination by age and educational level. Journal of American Medical Association. 1993;269:2386–2391. [PubMed]
  • Cummings JL. Mini-Mental State Examination: norms, normals and numbers. Journal of American Medical Association. 1993;269:2420–2421. [PubMed]
  • Currie SR, Clark S, Hodgins DC, et al. Randomized controlled trial of brief cognitive–behavioural interventions for insomnia in recovering alcoholics. Addiction. 2004;99:1121–1132. [PubMed]
  • Curtis L. Unit Costs of Health and Social Care. Canterbury: Personal Social Services Research Unit, University of Kent; 2009.
  • Curtis JR, Geller G, Stokes EJ, et al. Characteristics, diagnosis and treatment of alcoholism in elderly patients. Journal of the American Geriatric Society. 1989;37:310–316. [PubMed]
  • Daeppen JB, Gache P, Landry U, et al. Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Archives of Internal Medicine. 2002;162:1117–1121. [PubMed]
  • Dakof GA, Tejeda M, Liddle HA. Predictors of engagement in adolescent drug abuse treatment. Journal of the American Academy of Child & Adolescent Psychiatry. 2001;40:274–281. [PubMed]
  • Dansky BS, Brewerton TD, Kilpatrick DG. Comorbidity of bulimia nervosa and alcohol use disorders: results from the National Women’s Study. International Journal of Eating Disorders. 2000;27:180–190. [PubMed]
  • Dar K. Alcohol use disorders in elderly people: fact or fiction? Advances in Psychiatric Treatment. 2006;12:173–181.
  • Davidson D, Gulliver SB, Longabaugh R, et al. Building better cognitive-behavioral therapy: is broad-spectrum treatment more effective than motivational enhancement therapy for alcohol-dependent patients treated with naltrexones? Journal of Studies on Alcohol and Drugs. 2007;68:238–247. [PubMed]
  • Davidson K, Scott J, Schmidt U, et al. Therapist competence and clinical outcome in the prevention of parasuicide by manual assisted cognitive behaviour therapy trial: the POPMACT study. Psychological Medicine. 2004;34:855–863. [PubMed]
  • Davis L, Uezato A, Newell J, et al. Major depression and comorbid substance use disorders. Current Opinion in Psychiatry. 2008;21:14–18. [PubMed]
  • Davis WT, Campbell L, Tax J, et al. A trial of “standard” outpatient alcoholism treatment vs. a minimal treatment control. Journal of Substance Abuse Treatment. 2002;23:9–19. [PubMed]
  • Davison GC. Stepped care: doing more with less? Journal of Consulting and Clinical Psychology. 2000;68:580–585. [PubMed]
  • Dawe S, Rees VW, Mattick R, et al. Efficacy of moderation-orientated cue exposure for problem drinkers: a randomized controlled trial. Journal of Consulting and Clinical Psychology. 2002;70:1045–1050. [PubMed]
  • Dawson DA, Grant BF, Stinson FS, et al. Recovery from DSM–IV alcohol dependence: United States, 2001–2002. Addiction. 2005;100:281–292. [PubMed]
  • Dawson DA, Grant BF, Stinson FS. The AUDIT-C: screening for alcohol use disorders and risk drinking in the presence of other psychiatric disorders. Comprehensive Psychiatry. 2005;46:405–416. [PubMed]
  • Dawson DA, Grant BF, Chou SP, et al. The impact of partner alcohol problems on women’s physical and mental health. Journal of Studies on Alcohol and Drugs. 2007;68:66–75. [PubMed]
  • Dawson DA, Goldstein RB, Chou PS, et al. Age at first drink and the first incidence of adult-onset DSM–IV alcohol use disorders. Alcoholism: Clinical and Experimental Research. 2008;32:2149–2160. [PMC free article] [PubMed]
  • Day E, Ison J, Keaney F, et al. A National Survey of Inpatient Drug Treatment Services in England. London: National Treatment Agency for Substance Misuse; 2005.
  • Day EJ, Patel J, Georgiou G. Evaluation of a symptom-triggered front-loading 27 detoxification technique for alcohol dependence: a pilot study. Psychiatric Bulletin. 2004;28:407–410.
  • DeCaroulis DD, Rice KL, Ho L, et al. Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit. Pharmacotherapy. 2007;27:510–518. [PubMed]
  • De Maeyer J, Vanderplasschen W, Broekaert E. Exploratory study on drug users’ perspectives on quality of life: more than health-related quality of life? Social Indicators Research. 2008;90:107–126.
  • Deacon L, Hughes S, Tocque K, et al. Indications of Public Health in English Regions: 8. Alcohol. York: Association of Public Health Observatories; 2007.
  • Deeks JJ. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Statistics in Medicine. 2002;21:1575–1600. [PubMed]
  • Demirbas H, Celik S, Ilhan IO, et al. An examination of suicide probability in alcohol in-patients. Alcohol and Alcoholism. 2003;38:67–70. [PubMed]
  • Dennis M, Titus J, White M, et al. Global Appraisal of Individual Needs (GAIN): Administration Guide for the GAIN and Related Measures. Bloomington, IL: Chestnut Health Systems; 2002.
  • Dennis M, Godley SH, Diamond G, et al. The Cannabis Youth Treatment study: main findings from two randomised trials. Journal of Substance Abuse Treatment. 2004;27:197–213. [PubMed]
  • Department for Children, Schools and Families, National Treatment Agency & Department of Health. Joint Guidance on Development of Local Protocols between Drug and Alcohol Treatment Services and Local Safeguarding and Family Services. London: DCSF, DH & NTA; 2009.
  • Department of Health, Home Office. Safe. Sensible. Social. The Next Steps in the National Alcohol Strategy. London: Department of Health; 2007.
  • Department of Health. Sensible Drinking: the Report of an Inter-Departmental Working Group. London: Department of Health; 1995.
  • Department of Health. National Service Framework for Mental Health: Modern Standards and Service Models. London: Department of Health; 1999.
  • Department of Health. Models of Care for Alcohol Misusers. London: National Treatment Agency; 2006. [January 2011]. Available at: http://www​​/en/Publicationsandstatistics​/Publications​/PublicationsPolicyAndGuidance​/DH_4136806.
  • Department of Health. Clinical Management of Drug Dependence in the Adult Prison Setting. London: Department of Health; 2006.
  • Department of Health. Best Practice in Managing Risk: Principles and Evidence for Best Practice in the Assessment and Management of Risk to Self and Others in Mental Health Services. London: Department of Health; 2007.
  • Department of Health. The Cost of Alcohol Harm to the NHS in England. London: Department of Health; 2008.
  • Department of Health. Pregnancy and Alcohol. London: Department of Health; 2008.
  • Department of Health. NHS Reference Costs 2008–09. London: Department of Health; 2010. [11 May 2010]. Available from: http://www​​/en/Publicationsandstatistics​/Publications​/PublicationsPolicyAndGuidance​/DH_111591.
  • Department of Transport. Reported Road Casualties in Great Britain: 2008 Annual Report. London: Department of Transport; 2009.
  • DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials. 1986;7:177–188. [PubMed]
  • DeRubeis RJ, Feeley M. Determinants of change in cognitive therapy for depression. Cognitive Therapy and Research. 1990;14:469–482.
  • DeRubeis RJ, Hollon SD, Amsterdam JD, et al. Cognitive therapy versus medications in the treatment of moderate to severe depression. Archives of General Psychiatry. 2005;62:409–416. [PubMed]
  • De Sousa A, De Sousa A. A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence. Alcohol and Alcoholism. 2004;39:528–531. [PubMed]
  • De Sousa A, De Sousa A. An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence. Alcohol and Alcoholism. 2005;40:545–548. [PubMed]
  • De Sousa AA, De Sousa JA. An open randomised trial comparing disulfiram and topiramate in the treatment of alcohol dependence. Journal of Substance Abuse. 2008;34:460–463. [PubMed]
  • DfES. Every Parent Matters. London: Department for Education and Schools; 2007. [May 2010]. Available from:http://publications​.everychildmatters​.gov​.uk/eOrderingDownload/DFES-LKDA-2007​.pdf.
  • Dick DM, Plunkett J, Hamlin D, et al. Association analyses of the serotonin transporter gene with lifetime depression and alcohol dependence in the Collaborative Study on the Genetics of Alcoholism (COGA) sample. Psychiatric Genetics. 2007;17:35–38. [PubMed]
  • DiClemente CC, Hughes SO. Stages of change profiles in alcoholism treatment. Journal of Substance Abuse. 1990;2:217–235. [PubMed]
  • Donovan DM, Kivlahan DR, Doyle SR, et al. Concurrent validity of the Alcohol Use Disorders Identification Test (AUDIT) and AUDIT zones in defining levels of severity among out-patients with alcohol dependence in the COMBINE study. Addiction. 2006;101:1696–704. [PubMed]
  • Drake RE, McHugo GJ, Clark RE, et al. Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry. 1998;68:201–215. [PubMed]
  • Driessen M, Meier S, Hill A, et al. The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol and Alcoholism. 2001;36:249–255. [PubMed]
  • Drobes DJ, Anton RF, Thomas SE, et al. Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers. Alcoholism: Clinical & Experimental Research. 2004;28:1362–70. [PubMed]
  • Drummond C. The relationship between alcohol dependence and alcohol-related problems in a clinical population. British Journal of Addiction. 1990;85:357–366. [PubMed]
  • Drummond C. Treatment services for alcohol use disorders, The New Oxford Textbook of Psychiatry. 2. Gelder M, Andreasen N, Lopez-Ibor J, et al., editors. Oxford: Oxford University Press; 2009.
  • Drummond C, Ghodse H. Use of investigations in the diagnosis and management of alcohol use disorders. Advances in Psychiatric Treatment. 1999;5:366–375.
  • Drummond DC, Oyefeso N, Phillips T, et al. Alcohol Needs Assessment Research Project (ANARP): The 2004 National Alcohol Needs Assessment for England. London: Department of Health; 2005.
  • Drummond C, Ghodse H, Chengappa S. Use of investigations in the diagnosis and management of alcohol use disorders, Clinical Topics in Addictions. Day EJ, editor. London: RCPsych Publications; 2007.
  • Drummond C, Coulton S, James D, et al. Effectiveness and cost-effectiveness of a stepped care intervention for alcohol use disorders in primary care: pilot study. The British Journal of Psychiatry. 2009;195:448–456. [PubMed]
  • Drummond DC. What does cue reactivity have to offer craving research. Addiction. 2000;95(Suppl. 2):S129–S144. [PubMed]
  • Drummond DC, Phillips TS. Alcohol urges in alcohol-dependent drinkers: further validation of the Alcohol Urge Questionnaire in an untreated community clinical population. Addiction. 2002;97:1465–1472. [PubMed]
  • Drummond DC, Cooper T, Glautier SP. Conditioned learning in alcohol dependence implications for cue exposure treatment. British Journal of Addiction. 1990;85:725–743. [PubMed]
  • Drummond LM, Chalmers L. Prescribing chlormethiazole reducing regimes in an emergency clinic. British Journal of Addiction. 1986;81:247–250. [PubMed]
  • Dunn ME, Goldman MS. Age and drinking-related differences in the memory organization of alcohol expectancies in 3rd, 6th, 9th, and 12th grade children. Journal of Consulting & Clinical Psychology. 1998;66:579–585. [PubMed]
  • Dukan JK, Reed DN, Looney SW, et al. Risk factors for delirium tremens in trauma patients. Journal of Trauma. 2002;53:901–906. [PubMed]
  • DVLA. For Medical Practitioners: At a Glance Guide to the current Medical Standards of Fitness to Drive. Swansea: Drivers Medical Group DVLA; 2010. [16 February 2011]. Available from: http://www​​/dvla/medical/ataglance.aspx.
  • Dyson J. Experience of alcohol dependence: a qualitative study. Journal of Family Health Care. 2007;17:211–214. [PubMed]
  • Easton CJ, Mandel DL, Hunkele KA, et al. A cognitive behavioural therapy for alcohol-dependent domestic violence offenders: an integrated substance abuse-domestic violence treatment approach (SADV) The American Journal on Addictions. 2007;16:24–31. [PubMed]
  • Eccles M, Freemantle N, Mason J. North of England evidence based guideline development project: methods of developing guidelines for efficient drug use in primary care. British Medical Journal. 1998;316:1232–1235. [PMC free article] [PubMed]
  • Edwards G, Guthrie S. A comparison of inpatient and outpatient treatment of alcohol dependence. Lancet. 1966;1:467–458. [PubMed]
  • Edwards G, Gross MM. Alcohol dependence: provisional description of a clinical syndrome. British Medical Journal. 1976;1:1058–1061. [PMC free article] [PubMed]
  • Edwards G, Brown D, Oppenheimer E, et al. Long term outcome for patients with drinking problems: the search for predictors. British Journal of Addiction. 1988;83:917–927. [PubMed]
  • Edwards G, Marshall EJ, Cook CC. The Treatment of Drinking Problems: A Guide for the Helping Professions. 4. New York: Cambridge University Press; 2003.
  • Elkin I. The NIMH treatment of depression collaborative research programme: where we began and where we are, Handbook of Psychotherapy and Behaviour Change. 4. Bergin AE, Garfield SL, editors. New York, NY: Wiley; 1994.
  • Elkin I, Shea MT, Watkins J, et al. National Institute of Mental Health Treatment of Depression Collaborative Research Programme. General effectiveness of treatments. Archives of General Psychiatry. 1989;46:971–982. [PubMed]
  • Emrick CD. A review of psychologically oriented treatment of alcoholism: I. The use and inter-relationships of outcome criteria and drinking behaviour following treatment. Quarterly Journal of Studies on Alcohol. 1974;35:523–549. [PubMed]
  • Errico AL, Nixon SJ, Parsons OA, et al. Screening for neuropsychological impairment in alcoholics. Psychological Assessment: A Journal of Consulting and Clinical Psychology. 1990;2:45–50.
  • Errico AL, Parsons OA, King AC. Assessment of verbosequential and visuospatial cognitive abilities in chronic alcoholics. Psychological Assessment: Journal of Consulting and Clinical Psychology. 1991;3:693–696.
  • Eriksen L. The effect of waiting for inpatient alcoholism treatment after detoxification: An experimental comparison between inpatient treatment and advice only. Addictive Behaviours. 1986;11:389–397. [PubMed]
  • Eriksen L, Björnstad. &, Götestam G. Social skills training in groups for alcoholics: One-year treatment outcome for groups and individuals. Addictive Behaviors. 1986;11:309–329. [PubMed]
  • Escobar JI, Burnam A, Karno M, et al. Use of the Mini-Mental State Examination (MMSE) in a community population of mixed ethnicity: cultural and linguistic artifacts. The Journal of Nervous and Mental Disease. 1986;174:607–614. [PubMed]
  • Essock SM, Mueser KT, Drake RE, et al. Comparison of ACT and standard case management for delivering integrated treatment for co-occurring disorders. Psychiatric Services. 2006;57:185–196. [PubMed]
  • Evans SM, Levin FR, Brooks DJ, et al. A pilot double-blind trial of memantine for alcohol dependence. Alcoholism: Clinical and experimental Research. 2007;31:775–782. [PubMed]
  • Everitt BJ, Belin D, Economidou D, et al. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philosophical Transactions of the Royal Society (Series B) Biological Sciences. 2008;363:3125–3135. [PMC free article] [PubMed]
  • Evert DL, Oscar-Berman M. Alcohol-related cognitive impairments: an overview of how alcoholism may affect the workings of the brain. Alcohol Health & Research World. 1995;19:89–96.
  • Falk DE, Yi HY, Hiller-Sturmhofel S. An epidemiologic analysis of co-occurring alcohol and tobacco use and disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Alcohol Research & Health. 2006;29:169–171. [PubMed]
  • Fals-Stewart W, Klostermann K. Psychoeducational Attention Control Treatment for Alcoholism (PACT): A Guide. Buffalo, NY: The Addiction and Family Research Group; 2004.
  • Fals-Stewart W, Klosterman K, Yates BT, et al. Brief relationship therapy for alcoholism: A randomized clinical trial examining clinical efficacy and cost-effectiveness. Psychology of Addictive Behaviors. 2005;19:363–371. [PubMed]
  • Fals-Stewart W, O’Farrell TJ, Birchler GR, et al. Standard Behavioral Couples Therapy for Alcoholism (S-BCT): A Guide. Buffalo, NY: Addiction and Family Research Group; 2004.
  • Fals-Stewart W, Birchler GR, Kelley ML. Learning sobriety together: a randomized clinical trial examining behavioral couple’s therapy with alcoholic female patients. Journal of Consulting and Clinical Psychology. 2006;74:579–591. [PubMed]
  • Farrell M, Cowing LR, Marsden J, et al. Substitution treatment for opioid dependence: a review of the evidence and the impact. Development and Improvement of Substitution Programmes: Proceedings Seminar Organized by the Co-operation Group to Combat Drug Abuse and Illicit Trafficking in Drugs (Pompidou Group); Strasbourg, France. 8–9 October 2001; Strasbourg: Council of Europe; 2001.
  • Farren CK, Scimeca M, Wu R, et al. A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence. Drug and Alcohol Dependence. 2009;99:317–321. [PMC free article] [PubMed]
  • Feeley M, DeRubeis RJ, Gelfand LA. The temporal relation of adherence and alliance to symptom change in cognitive therapy for depression. Journal of Consulting and Clinical Psychology. 1999;67:578–582. [PubMed]
  • Feldman DJ, Pattison EM, Sobell LC, et al. Outpatient alcohol detoxification: initial findings on 564 patients. American Journal of Psychiatry. 1975;132:407–412. [PubMed]
  • Fenwick E, Klaxton K, Schulpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Economics. 2001;10:779–787. [PubMed]
  • Ferguson JA, Suelzer CJ, Eckert GJ, et al. Risk factors for delirium tremens development. Journal of General Internal Medicine. 1996;11:410–414. [PubMed]
  • Ferri M, Amato L, Davoli M. Alcoholics Anonymous and other 12-step programmes for alcohol dependence. Cochrane Database of Systematic Reviews. 2006;(3):CD005032. [PubMed]
  • Finney JW, Moos RH, Brennan PL. The Drinking Problems Index: a measure to assess alcohol-related problems among older adults. Journal of Substance Abuse. 1991;3:395–404. [PubMed]
  • Finney JW, Hahn AC, Moos RH. The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderators of setting effects. Addiction. 1996;91:1773–1796. [PubMed]
  • Fiore MC, Jaen CR, Baker TB, et al. Clinical Practice Guideline: Treating Tobacco Use and Dependence. Rockville, MD: Department of Health and Human Services; 2008.
  • Fisher P, Schaffer D, Piacentini JC, et al. Sensitivity of the Diagnostic Interview Schedule for Children, 2nd Edition (DISC-2.1) for specific diagnosis of children and adolescents. Journal of American Academy of Child and Adolescent Psychiatry. 1993;32:666–673. [PubMed]
  • Flatley J, Kershaw C, Smith K, et al. Crime in England and Wales 2009/10. Volume 1. Findings from the British Crime Survey and Police Recorded Crime. London: Home Office; 2010.
  • Fleming MF, Barry KL, MacDonald R. The Alcohol Use Disorders Identification Test (AUDIT) in a college sample. International Journal of the Addictions. 1991;26:1173–1185. [PubMed]
  • Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychological Research. 1975;12:189–198. [PubMed]
  • Ford P. An evaluation of the Dartmouth Assessment of Lifestyle Inventory and the Leeds Dependence Questionnaire for use among detained psychiatric inpatients. Addiction. 2003;98:111–118. [PubMed]
  • Foreman MD. Reliability and validity of mental status questionnaires in elderly hospitalized patients. Nursing Research. 1987;36:216–220. [PubMed]
  • Frank D, DeBenedetti AF, Volk RJ, et al. Effectiveness of the AUDIT-C as a screening tests for alcohol misuse in three race/ethnic groups. Journal of General Internal Medicine. 2008;23:781–787. [PMC free article] [PubMed]
  • Freimanis L. Alcohol and single homelessness: an outreach approach, Homelessness, Health Care and Welfare Provision. Fisher K, Collins J, editors. London: Routledge; 1993. pp. 44–51.
  • Fuller E. Drug Use, Smoking and Drinking Among Young People in England in 2007. National Centre for Social Research, National Foundation for Educational Research; 2008.
  • Fuller E, Jotangia D, Farrell M. Alcohol misuse and dependence, Adult Psychiatric Morbidity in England, 2007 Results of a Household Survey. McManus S, Meltzer H, Brugha T, et al., editors. Leeds: NHS Information Centre for Health and Social Care; 2009.
  • Fuller RK, Roth HP. Disulfiram for the treatment of alcoholism: An evaluation of 128 men. Annals of Internal Medicine. 1979;90:901–904. [PubMed]
  • Fuller RK, Branchey L, Brightwell DR, et al. Disulfiram treatment of alcoholism: a veterans administration cooperative study. Journal of the American Medical Association. 1986;256:1449–1455. [PubMed]
  • Furieri FA, Nakamura-Palacios EM. Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial. Journal of Clinical Psychiatry. 2007;68:1691–1700. [PubMed]
  • Furukawa TA, Barbui C, Cipriani A, et al. Imputing missing standard deviations in meta-analyses can provide accurate results. Journal of Clinical Epidemiology. 2006;59:7–10. [PubMed]
  • Gadalla T, Piran N. Co-occurrence of eating disorders and alcohol use disorders in women: a meta-analysis. Archives of Women’s Mental Health. 2007;10:133–140. [PubMed]
  • Gance-Cleveland B. Qualitative evaluation of a school-based support group for adolescents with an addicted parent. Nursing Research. 2004;53:379–386. [PubMed]
  • Ganguli M, Ratcliff G, Chandra V, et al. A Hindi version of the MMSE: the development of a cognitive screening instrument for a largely illiterate rural elderly population in India. International Journal of Geriatric Psychiatry. 1995;10:367–377.
  • Garbutt JC, Kranzler HR, O’Malley SS, et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence. The Journal of the American Medical Association. 2005;293:1671–1625. [PubMed]
  • Garbutt JC, Osborne M, Gallop. R, et al. Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence. Alcohol and Alcoholism. 2009;44:293–300. [PMC free article] [PubMed]
  • Gastpar M, Bonnet U, Boning J, et al. Lack of efficacy of naltrexone in the prevention of alcohol relapse: Results from a german multicenter study. Journal of Clinical Psychopharmacy. 2002;22:592–598. [PubMed]
  • Gates S, Smith LA, Foxcroft DR. Auricular acupuncture for cocaine dependence. Cochrane Database Systematic Review. 2006:CD005192. [PubMed]
  • Gaval-Cruz M, Weinshenker D. Mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse. Molecular Interventions. 2009;9:175–187. [PMC free article] [PubMed]
  • Geerlings PJ, Ansoms C, Van der Brink W. Acamprosate and prevention of relapse in alcoholics. European Addiction Research. 1997;3:129–137.
  • Gelernter J, Gueorguieva R, Kranzler HR, et al. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA cooperative study. Alcoholism: Clinical & Experimental Research. 2007;31:555–563. [PubMed]
  • Gerrein JR, Rosenberg CM, Manohar V. Disulfiram maintenance on outpatient treatment of alcoholism. Archives of General Psychiatry. 1973;28:798–802. [PubMed]
  • Ghodse H., Royal College of Psychiatrists’ Medical Working Group. Substance Misuse Detainees in Police Custody: Guidleines for Clinical Management. 3rd edn. London: Royal College of Psychiatrists; 2006. Council Report CR132.
  • Ghodse H, Checinski K, Drummond C, et al. St Georges Hospital Medical School Department of Psychiatry of Addictive Behaviour. Handbook. 4. London: St George’s Hospital Medical School; 1998.
  • Gilbert F. The effect of type of aftercare of follow-up on treatment outcome among alcoholics. Journal of Studies on Alcohol. 1988;49:149–159. [PubMed]
  • Gilchrist G, Morrison D. Prevalence of alcohol related brain damage among homeless hostel dwellers in Glasgow. European Journal of Public Health. 2004;15:587–588. [PubMed]
  • Giles HG, Sandrin S. Alcohol and deaths in police custody. Alcoholism. 1990;16:670–672. [PubMed]
  • Gill B, Meltzer H, Hinds K, et al. Psychiatric Morbidity among Homeless People. OPCS Surveys of Psychiatric Morbidity in Great Britain, Report 7. London: Her Majesty’s Stationary Office; 1996.
  • Gillen RW, Kranzler HR, Kadden RM, et al. Utility of a brief cognitive screening instrument in substance abuse patients: initial investigation. Journal of Substance Abuse Treatment. 1991;8:247–251. [PubMed]
  • Glasner-Edwards S, Tate SR, McQuaid JR, et al. Mechanisms of action in integrated cognitive-behavioral treatment versus Twelve-Step Facilitation for substance-dependent adults with comorbid major depression. Journal of Studies on Alcohol and Drugs. 2007;68:663–672. [PubMed]
  • Gleeson D, Jones JS, McFarlane E, et al. Severity of alcohol dependence in decompensated alcoholic liver disease: comparison with heavy drinkers without liver disease and relationship to family drinking history. Alcohol & Alcoholism. 2009;44:392–397. [PubMed]
  • Goddard E. General Household Survey 2006, Smoking and Drinking Among Adults. London: Office for National Statistics; 2006.
  • Goldman D, Oroszi G, Ducci F. The genetics of addictions: uncovering the genes. Nature Reviews Genetics. 2005;6:521–532. [PubMed]
  • Goldstein RB, Dawson DA, Saha TD, et al. Antisocial behavioral syndromes and DSM–IV alcohol use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Alcoholism: Clinical and Experimental Research. 2007;31:814–828. [PubMed]
  • Gordon DA, Graves K, Arbuthnot J. The effect of functional family therapy for delinquents on adult criminal behavior. Criminal Justice and Behavior. 1995;22:60–73.
  • Gordon HW. The Cognitive Laterality Battery: tests of specialized cognitive function. International Journal of Neuroscience. 1986;29:223–244. [PubMed]
  • Gossop M. Withdrawal and detoxification, Drug Addiction and its Treatment. Oxford: Oxford University Press; 2003. pp. 115–136.
  • Gossop M, Marsden J, Stewart D, et al. The national treatment outcome research study (NTORS): 4–5 year follow-up results. Addiction. 2003;98:291–303. [PubMed]
  • Gossop M, Manning V, Ridge G. Concurrent use of alcohol and cocaine: Differences in patterns of use and problems among users of crack cocaine and cocaine powder. Alcohol & Alcoholism. 2006;41:121–125. [PubMed]
  • Grades of Recommendation Assessment, Development and Evaluation (GRADE) Working Group. Grading quality of evidence and strength of recommendations. British Medical Journal. 2004;328:1490–1497. [PMC free article] [PubMed]
  • Grant BF, Stinson FS, Dawson DA, et al. Prevalence and cooccurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry. 2004;61:807–816. [PubMed]
  • Grant BF, Hasin DS, Chou SP, et al. Nicotine dependence and psychiatric disorders in the United States. Archives of General Psychiatry. 2004;61:1107–1115. [PubMed]
  • Gregg E, Akhter I. Chlormethiazole abuse. British Journal of Psychiatry. 1979;134:627–629. [PubMed]
  • Gregory RJ, Chlebowski S, Kang D, et al. A controlled trial of psychodynamic psychotherapy for co-occurring borderline personality disorder and alcohol use disorder. Psychotherapy: Theory, Research, Practice, Training. 2008;45:28–41. [PubMed]
  • Griffiths RR, Wolf B. Relative abuse liability of different benzodiazepeines in drug abusers. Journal of Clinicial Psychopharmacology. 1990;10:237–243. [PubMed]
  • Gual A, Lehert P. Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain. Alcohol & Alcoholism. 2001;36:413–418. [PubMed]
  • Gual A, Segura L, Contel M, et al. AUDIT-3 and AUDIT-4: effectiveness of two short forms of the alcohol use disorders identification test. Alcohol and Alcoholism. 2002;37:61–66. [PubMed]
  • Guardia J, Caso C, Arias F, et al. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial. Alcoholism: Clinical and Experimental Research. 2002;26:1381–1387. [PubMed]
  • Haddad LB, Coffman TL. A brief neuropsychological screening exam for psychiatric geriatric patients. Clinical Gerontologist. 1987;6:3–10.
  • Happell B, Taylor C. Drug and alcohol education for nurses: have we examined the whole problem? Journal of Addictions Nursing. 1999;11:180–185.
  • Hardern R, Page AV. An audit of symptom triggered chlordiazepoxide treatment of alcohol withdrawal on a medical admissions unit. Emergency Medicine Journal. 2005;22:805–806. [PMC free article] [PubMed]
  • Harper C. Wernicke’s encephalopathy: a more common disease than realised. Journal of Neurology, Neurosurgery, and Psychiatry. 1979;42:226–231. [PMC free article] [PubMed]
  • Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. Journal of Neurology, Neurosurgery, and Psychiatry. 1986;49:341–345. [PMC free article] [PubMed]
  • Harrell A, Wirtz PW. Adolescent Drinking Index. Odessa, FL: Psychological Assessment Resources; 1990.
  • Harrell AV, Wirtz PW. The Adolescent Drinking Index Professional Manual. Odessa, FL: Psychological Assessment Resources; 1985.
  • Harrington R, Kerfoot. M, Verduyn C. Developing needs led child and adolescent mental health services: issues and prospects. European Child & Adolescent Psychiatry. 1999;8:1018–8827. [PubMed]
  • Harrison L, Luck H. Drinking and homelessness, Alcohol Problems in the Community. Harrison L, editor. London: Routledge; 1997. pp. 53–75.
  • Hartney E, Orford J, Dalton S, et al. Untreated heavy drinkers: a qualitative and quantitative study of dependence and readiness to change. Addiction Research and Theory. 2003;11:317–337.
  • Hasin DS, Trautman KD, Miele GM, et al. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. American Journal of Psychiatry. 1996;153:1195–1201. [PubMed]
  • Hawton K, Bergen H, Casey D, et al. Self-harm in England: a tale of three cities: multicentre study of self-harm. Social Psychiatry and Psychiatric Epidemiology. 2007;42:513–521. [PubMed]
  • Hayashida M, Alterman AI, McLellan AT, et al. Comparative effectiveness and costs of in-patient and out-patient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome. New England Journal of Medicine. 1989;320:358–365. [PubMed]
  • Hays RD, Men JF, Nicholas R. Response burden, reliability, and validity of the CAGE, Short MAST, and IT alcohol screening measures. Behaviour Research Methods, Instruments & Computers. 1995;27:277–280.
  • Head J, Martikainen P, Kumari M, et al. Work Environment, Alcohol Consumption and Ill-Health. The Whitehall II Study. Norwich: HMSO; 2002.
  • Healy D, Nutt D. Prescriptions, licenses and evidence. The Psychiatrist. 1998;22:680–684.
  • Heather N, Hönekopp J. A revised edition of the Readiness to Change Questionnaire (treatment version) Addiction Research and Theory. 2008;16:421–433.
  • Heather N, Luce A, Peck D, et al. Development of a treatment version of the Readiness to Change Questionnaire. Addiction Research. 1999;7:63–83.
  • Heather N, Brodie J, Wale S, et al. A randomized controlled trial of moderation-orientated cue exposure. Journal of Studies on Alcohol. 2000;61:561–570. [PubMed]
  • Heather N, Raistrick D, Tober G, et al. Leeds Dependence Questionnaire: new data from a large sample of clinic attenders. Addiction Research & Theory. 2001;9:253–269.
  • Heather N, Adamson SJ, Raistrick D, et al. UKATT Research Team. Initial preference for drinking goal in the treatment of alcohol problems: I. Baseline differences between abstinence and non-abstinence groups. Alcohol & Alcoholism. 2010;45:128–135. [PubMed]
  • Hecksel KA, Bostwick M, Jaeger TM, et al. Inappropriate use of symptom-triggered therapy for alcohol withdrawal in the general hospital. Mayo Clinic Proceedings. 2008;83:274–279. [PubMed]
  • Heinala P, Alho H, Kiianma K, et al. Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology. 2001;21:287–292. [PubMed]
  • Heinz A. Dopaminergic dysfunction in alcoholism and schizophrenia-psychopathological and behavioral correlates. European Psychiatry. 2002;17:9–16. [PubMed]
  • Henggeler SW, Melton GB, Smith LA. Family preservation using multisystematic therapy: an effective alternative to incarcerating serious juvenile offenders. Journal of Consulting and Clinical Psychology. 1992;60:953–961. [PubMed]
  • Henggeler S, Pickrel S, Brondino M. Multisystemic treatment of substance-abusing and dependent delinquent: outcomes, treatment fidelity and transportability. Mental Health Services Research. 1999;1:171–184. [PubMed]
  • Hershey LA, Jaffe DF, Greenough PG, et al. Validation of cognitive and functional assessment instruments in vascular dementia. International Journal of Psychiatry in Medicine. 1987;17:183–192. [PubMed]
  • Herz A. Neurobiological principles of drug dependence. Exemplified by opioids and psychostimulants. Der Nervenarzt. 1997;66:3–14. [PubMed]
  • Hesse M. Achieving abstinence by treating depression in the presence of substance-use disorders. Addictive Behaviors. 2004;29:1137–1141. [PubMed]
  • Hester RK, Squires DD, Delaney HD. The Drinker’s Check-up: 12-month outcomes of a controlled clinical trial of a stand-alone software program for problem drinkers. Journal of Substance Abuse Treatment. 2005;28:159–169. [PubMed]
  • Hibell B, Guttormsson U, Ahlström S, et al. The 2007 ESPAD Report: Substance Use Among Students in 35 European Countries. Stockholm: The Swedish Council for Information on Alcohol and Other Drugs; 2009.
  • Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine. 2002;21:1539–1558. [PubMed]
  • Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2. 2009. [updated September 2009]. The Cochrane Collaboration 2009. Available from: www​
  • Higgins JPT, Whitehead A. Borrowing strength from external trials in a meta-analysis. Statistics in Medicine. 1996;15:2733–2749. [PubMed]
  • Hingson R, Zha W. Age of drinking onset, alcohol use disorders, frequent heavy drinking, and unintentionally injuring oneself and others after drinking. Pediatrics. 2009;123:1477–1484. [PubMed]
  • Hingson R, Heeren T, Winter M. Age of alcohol-dependence onset: associations with severity of dependence and seeking treatment. Pediatrics. 2006;118:e755–e763. [PubMed]
  • HMSO. The Children Act 2004. London: The Stationary Office; 2004. [April 2011]. Available at: http://www​.legislation​
  • Hodgson RJ, Rankin HJ. Modification of excessive drinking by cue exposure. Behaviour Research and Therapy. 1976;14:305–307. [PubMed]
  • Hoffmann NG, Harrison PA. SUDDS-IV: Substance Use Disorder Diagnostic Schedule-IV. St Paul, MN: New Standards, Inc.; 1995.
  • Hoffman PL, Tabakoff B. Alcohol dependence: a commentary on mechanisms. Alcohol & Alcoholism. 1996;31:333–340. [PubMed]
  • Holder HD, Cisler RA, Longabaugh R, et al. Alcoholism treatment and medical care costs from Project MATCH. Addiction. 2000;95:999–1013. [PubMed]
  • Hollis V. Reconviction Analysis of Programme Data using Interim Accredited Programmes Software (IAPS) London: RDS/NOMS; 2007.
  • Hollon SD, Evans MD, Auerbarch A, et al. Development of a System for Rating Therapies for Depression: Differentiating Cognitive Therapy, Interpersonal Psychotherapy, and Clinical Management. Nashville, TN: Vanderbilt University; 1988. Unpublished manuscript.
  • Horder JM. Fatal chlormethiazole poisoning in chronic alcoholics. British Medical Journal. 1978;1:693–694. [PMC free article] [PubMed]
  • Horvath AO, Symonds BD. Relation between working alliance and outcome in psychotherapy: meta-analysis. Journal of Counseling Psychology. 1991;38:139–149.
  • Huang MC, Chen CH, Yu JM, et al. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan. Addiction Biology. 2005;10:289–292. [PubMed]
  • Hughes JR. Clinical implications of the association between smoking and alcoholism, Alcohol and Tobacco: From Basic Science to Policy NIAAA Research Monograph. Fertig J, Fuller R, editors. Vol. 30. Washington, DC: US Government Printing Office; 1995. pp. 171–181.
  • Hughes JT, Kalman D. Do smokers with alcohol problems have more difficulty quitting? Drug and Alcohol Dependence. 2006;82:91–102. [PubMed]
  • Hunt GM, Azrin NH. A community reinforcement approach to alcoholism. Behavior Research and Therapy. 1973;11:91–104. [PubMed]
  • Hunt WA, Barnett LW, Branch LG. Relapse rates in addiction programs. Journal of Clinical Psychology. 1971;27:445–456. [PubMed]
  • Hyams G, Cartwright A, Spratley T, et al. Engagement in alcohol treatment: the client’s experience of, and satisfaction with, the assessment interview. Addiction Research & Theory. 1996;4:105–123.
  • Ilgen M, Tiet Q, Finney J, et al. Self-efficacy, therapeutic alliance, and alcohol-use disorder treatment outcomes. Journal of Studies on Alcohol. 2006;67:465–468. [PubMed]
  • Institute of Medicine. Homelessness, Health, and Human Needs. Washington, DC: National Academy Press; 1988.
  • Institute of Medicine. Reducing Underage Drinking: A Collective Responsibility. Washington, DC: National Academy Press; 2003.
  • Iype T, Ajitha BK, Antony P, et al. Usefulness of the Rowland Universal Dementia Assessment Scale in South India. Journal of Neurology, Neurosurgery, and Psychiatry. 2006;77:513–514. [PMC free article] [PubMed]
  • Jacobs JW, Bernhard MR, Delgado A, et al. Screening for organic mental syndromes in the medically ill. Annals of Internal Medicine. 1977;86:40–46. [PubMed]
  • Jacobson RR, Acker CF, Lishman WA. Patterns of neuropsychological deficit in alcoholic Korsakoff’s syndrome. Psychological Medicine. 1990;20:321–334. [PubMed]
  • Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary? Controlled Clinical Trials. 1996;17:1–12. [PubMed]
  • Jaeger TM, Lohr RH, Pankratz VS. Symptom-triggered therapy for alcohol withdrawal syndrome in medical inpatients. Mayo Clinic Proceedings. 2001;76:695–701. [PubMed]
  • Jensen P, Roper M, Fisher P, et al. Test-retest reliability of the Diagnostic Interview Schedule for Children (DISC-2.1), parent, child, and combined algorithms. Archives of General Psychiatry. 1995;52:61–71. [PubMed]
  • Jethwa H. Social and psychological aspects of alcohol misuse and dependence. Drugs and Alcohol Today. 2009;9:29–35.
  • John U, Veltrup C, Driessen M, et al. Motivational intervention: an individual counselling vs. a group treatment approach for alcohol-dependent inpatients. Alcohol and Alcoholism. 2003;38:263–269. [PubMed]
  • Johnson BA. Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochemical Pharmacology. 2008;75:34–56. [PMC free article] [PubMed]
  • Johnson BA, Roache JD, Javors MA, et al. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial. The Journal of the American Medical Association. 2000;284:963–971. [PubMed]
  • Johnson BA, Ait-Daoud N, Bowden CL, et al. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. The Lancet. 2003;361:1677–1685. [PubMed]
  • Johnson BA, Rosenthal N, Capece JA, et al. Topiramate for treating alcohol dependence: a randomized controlled trial. The Journal of the American Medical Association. 2007;298:1641–1651. [PubMed]
  • Jolliffe N, Wortis H, Fein HD. The Wernicke syndrome. Archives of Neurology and Psychiatry. 1941;46:569–597.
  • Jones L, Bellis MA, Dedman D, et al. Alcohol Attributable Fractions for England: Alcohol Attributable Mortality and Hospital Admissions. Liverpool: North West Public Health Observatory; 2008.
  • Jordan JB. Acupuncture treatment for opiate addiction: a systematic review. Journal of Substance Abuse Treatment. 2006;30:309–314. [PubMed]
  • Joseph AM, Willenbring ML, Nudent SM, et al. A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment. Journal of Studies on Alcohol. 2004;65:681–691. [PubMed]
  • Joyce EM. Aetiology of alcoholic brain damage: alcoholic neurotoxicity or thiamine malnutrition? British Medical Bulletin. 1994;50:99–114. [PubMed]
  • Kadden RM, Cooney NL, Getter H, et al. Matching alcoholics to coping skills or interactional therapies: post treatment results. Journal of Consultant & Clinical Psychology. 1989;57:698–704. [PubMed]
  • Kadden R, Carroll KM, Donovan D, et al. Cognitive-Behavioral Coping Skills Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence. Vol. 3. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism; 1992. 1995. NIAAA Project MATCH Monograph.
  • Kahan M, Borgundvaag B, Midmer D, et al. Treatment variability and outcome differences in the emergency department management of alcohol withdrawal. Canadian Journal of Emergency Medicine. 2005;7:87–92. [PubMed]
  • Kahler CW, Read JP, Stuart GL, et al. Motivational enhancement for 12-step involvement among patients undergoing alcohol detoxification. Journal of Consulting and Clinical Psychology. 2004;72:736–741. [PubMed]
  • Kalant H. Current state of knowledge about the mechanisms of alcohol tolerance. Addiction Biology. 1996;1:133–141. [PubMed]
  • Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. American Journal of Psychiatry. 2005;162:1403–1413. [PubMed]
  • Källmén H, Sjöberg L, Wennberg P. The effect of coping skills training on alcohol consumption in heavy social drinking. Substance Use & Misuse. 2003;38:895–903. [PubMed]
  • Kalman D, Hayes K, Colby SM, et al. Concurrent versus delayed smoking cessation treatment for persons in early alcohol recovery: a pilot study. Journal of Substance Abuse Treatment. 2001;20:233–238. [PubMed]
  • Kalman D, Kima S, DiGirolamoc G, et al. Addressing tobacco use disorder in smokers in early remission from alcohol dependence: the case for integrating smoking cessation services in substance use disorder treatment programs. Clinical Psychology Review. 2010;30:12–24. [PMC free article] [PubMed]
  • Kaminer Y, Burleson JA. Psychotherapies for adolescent substance abusers: 15-month follow-up of a pilot study. American Journal on Addictions. 1999;8:114–119. [PubMed]
  • Kaminer Y, Burkstein OG, Tarter RE. The Teen Addiction Severity Index: rationale and reliability. The International Journal of the Addictions. 1991;26:219–226. [PubMed]
  • Kaminer Y, Wagner E, Plummer B, et al. Validation of the Teen Addiction Severity Index (T-ASI): preliminary findings. American Journal on Addictions. 1993;2:250–254.
  • Kaminer Y, Burleson J, Blitz C, et al. Psychotherapies for adolescent substance abusers: a pilot study. Journal of Nervous and Mental Disease. 1998;186:684–690. [PubMed]
  • Kaminer Y, Burleson J, Goldberger R. Cognitive behaviour coping skills and psychoeducation therapies for adolescent substance abuse. Journal of Nervous and Mental Disease. 2002;190:737–745. [PubMed]
  • Kaminer Y, Burleson JA, Burker RH. The efficacy of aftercare for adolescents with alcohol use disorders: a randomised controlled study. Journal of the American Academy of Child and Adolescent Psychiatry. 2008;47:1405–1412. [PMC free article] [PubMed]
  • Kampman KM, Pettinati HM, Lynch KG, et al. Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence. Addictive Behaviors. 2009;34:581–586. [PMC free article] [PubMed]
  • Kandel D, Chen K, Warner LA, et al. Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population. Drug and Alcohol Dependence. 1997;44:11–29. [PubMed]
  • Kaner EFS, Masterson B. The role of general practitioners in treating alcohol dependent patients in the community. Journal of Substance Misuse. 1996;1:132–136.
  • Kaner E, Rapley T, May C. exploration of GPs’ drinking and their alcohol intervention practices. Family Practice. 2006;23:481–487. [PubMed]
  • Kao AH, Lu LY. Acupuncture procedure for treating drug addiction. American Journal of Acupuncture. 1974;2:201–207.
  • Karhuvaara S, Simojoki K, Virta A, et al. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study. Alcoholism: Clinical and Experimental Research. 2007;31:1179–1187. [PubMed]
  • Karno MP, Longabaugh R. Does matching matter? Examining matches and mismatches between patients attributes and therapy techniques in alcoholism treatment. Addiction. 2007;102:587–596. [PubMed]
  • Kaskutas LA, Ammon LN, Witbrodt J, et al. Understanding results from randomized trials: use of program- and client-level data to study medical and nonmedical treatment programs. Journal of Studies on Alcohol. 2005;66:682–687. [PubMed]
  • Kaskutas LA, Bond J, Humphreys K. Social networks as mediators of the effect of Alcoholics Anonymous. Addiction. 2002;97:891–900. [PubMed]
  • Katzman R, Zhang MY, Ouang-Ya-Qu, Wang ZY, et al. A Chinese version of the Mini-Mental State Examination; impact of illiteracy in a Shanghai dementia survey. Journal of Clinical Epidemiology. 1988;41:971–978. [PubMed]
  • Kavanagh DJ, Sitharthan G, Young RM, et al. Addition of cue exposure to cognitive-behavior therapy for alcohol misuse: a randomized trial with dysphoric drinkers. Addiction. 2006;101:1106–1116. [PubMed]
  • Kazantzis N, Deane FP, Ronan KR. Homework assignments in cognitive and behavioral therapy: A meta-analysis. Clinical Psychology: Science & Practice. 2000;7:189–202.
  • Kelly JF, Moos RH. Dropout from 12-step self-help groups: prevalence, predictors and counteracting treatment influences. Journal of Substance Abuse Treatment. 2003;24:241–250. [PubMed]
  • Kelly JF, Magill M, Slaymaker V, et al. Psychometric validiation of the Leeds Dependence Questionnaire (LDQ) in a young adult clinical sample. Addictive Behaviours. 2010;35:331–336. [PMC free article] [PubMed]
  • Keso L, Salaspuro M. Inpatient treatment of employed alcoholics: a randomized clinical trial on Hazelden-Type and traditional treatment. Alcoholism: Clinical and Experimental Research. 1990;14:584–589. [PubMed]
  • Kessler RC, Nelson CB, McGonagle KA, et al. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. The American Journal of Orthopsychiatry. 1996;66:17–31. [PubMed]
  • Kiefer F, Helwig H, Tarnaske T, et al. Pharmacological relapse prevention of alcoholism: clinical predictors of outcome. European Addiction Research. 2005;11:83–91. [PubMed]
  • Kiefer F, Jahn H, Tarnaske T, et al. Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism. Archives of General Psychiatry. 2003;60:92–99. [PubMed]
  • Killaspy H, Bebbington P, Blizard R, et al. The REACT study: randomised evaluation of assertive community treatment in north London. British Medical Journal. 2006;332:15–20. [PMC free article] [PubMed]
  • Killeen TK, Brady KT, Gold PB, et al. Effectiveness of naltrexone in a community treatment program. Alcoholism: Clinical and Experimental Research. 2004;28:1710–1717. [PubMed]
  • Kim H, Ramsay E, Hyewon Lee H, et al. Genome-wide association study of acute post-surgical pain in humans. Pharmacogenomics. 2009;10:171–179. [PMC free article] [PubMed]
  • Kingdon D, Tyrer P, Seivewright N, et al. The Nottingham study of neurotic disorder: influence of cognitive therapists on outcome. British Journal of Psychiatry. 1996;169:93–97. [PubMed]
  • Kirby KC, Marlowe DB, Festinger DS, et al. Community reinforcement training for family and significant others of drug abusers: a unilateral intervention to increase treatment entry of drug users. Drug and Alcohol Dependence. 1999;56:85–96. [PubMed]
  • Kissin B, Platz A, Su WH. Social and psychological factors in the treatment of chronic alcoholism. Journal of Psychiatric Research. 1970;8:13–27. [PubMed]
  • Kleber HD. Naltrexone. Journal of Substance Abuse Treatment. 1985;2:117–122. [PubMed]
  • Knapp G, Hartung J. Improved tests for a random effects meta-regression with a single covariate. Statistics in Medicine. 2003;22:2693–2710. [PubMed]
  • Kodl M, Fu SS, Joseph AM. Tobacco cessation treatment for alcohol-dependent smokers: when is the best time? Alcohol Health Research. 2006;29:203–207. [PubMed]
  • Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology. 2010;35:217–238. [PMC free article] [PubMed]
  • Kopelman MD, Thomson AD, Guerrini I, et al. The Korsakoff syndrome: Clinical aspects, psychology and treatment. Alcohol & Alcoholism. 2009;44:148–154. [PubMed]
  • Kouimtsidis C, Reynolds M, Hunt M, et al. Substance use in the general hospital. Addictive Behaviours. 2003;28:483–499. [PubMed]
  • Kranzler H, Abu-Hasaballah K, Tennen H, et al. Using daily interactive voice response technology to measure drinking and related behaviors in a pharmacotherapy study. Alcoholism: Clinical and Experimental Research. 2004;28:1060–1064. [PubMed]
  • Kranzler H, Tennen H, Armeli S, et al. Targeted naltrexone for problem drinkers. Journal of Clinical Psychopharmacology. 2009;29:350–357. [PMC free article] [PubMed]
  • Kranzler HR, Burleson JA, Brown J, et al. Fluoxetine treatment seems to reduce the beneficial effect of cognitive-behavioural therapy in type B alcoholics. Alcoholism: Clincial and Experimental Research. 1996;20:1534–1541. [PubMed]
  • Kranzler HR, Modesto-Lowe V, Van Kirk J. Naltrexone vs nefazodone for treatment of alcohol dependence: a placebo-controlled trial. Neuropsychopharmacology. 2000;22:493–503. [PubMed]
  • Kranzler HR, Armeli S, Tennen H, et al. Targeted naltrexone for early problem drinkers. Journal of Clinical Psychopharmacology. 2003;23:294–304. [PubMed]
  • Kraemer KL, Mayo-Smith MF, Calkins DR. Impact of age on the severity, course, and complications of alcohol withdrawal. Archives of Internal Medicine. 1997;157:2234–2241. [PubMed]
  • Kraemer KL, Roberts MS, Nicholas HJ, et al. Health utility ratings for a spectrum of alcohol-related health states. Medical Care. 2005;43:541. [PubMed]
  • Krishnamurthy R, VandeCreek L, Kaslow NJ, et al. Achieving competency in psychological assessment: directions for education and training. Journal of Clinical Psychology. 2004;60:725–739. [PubMed]
  • Kristenson H. How to get the best out of Antabuse. Alcohol and Alcoholism. 1995;30:775–783. [PubMed]
  • Krug I, Pinheiro AP, Bulik C, et al. Lifetime substance abuse, family history of alcohol abuse/dependence and novelty seeking in eating disorders: comparison study of eating disorder subgroups. Psychiatry and Clinical Neurosciences. 2009;63:82–87. [PubMed]
  • Krupski A, Campbell K, Joesch JM, et al. Impact of access to recovery services on alcohol/drug treatment outcomes. Journal of Substance Abuse Treatment. 2009;37:435–442. [PubMed]
  • Krystal AD, Thakur M, Roth T. Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia. Annals of Clinical Psychiatry. 2008;20:39–46. [PubMed]
  • Krystal JH, D’Souza DC, Petrakis IL, et al. NDMA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. Harvard Review of Psychiatry. 1999;7:125–143. [PubMed]
  • Krystal JH, Petrakis IL, Mason G, et al. N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability. Pharmacology & Therapeutics. 2003;99:79–94. [PubMed]
  • Krystal JH, Cramer JA, Krol WF, et al. Naltrexone in the treatment of alcohol dependence. The New England Journal of Medicine. 2001;345:1734–1739. [PubMed]
  • Krystal JH, Staley J, Mason G, et al. Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment. Archives of General Psychiatry. 2006;63:957–968. [PubMed]
  • Kunz S, Schulz M, Lewitzky M, et al. Ear acupuncture for alcohol withdrawal in comparison with aromatherapy: a randomized controlled trial. Alcoholism: Clinical and Experimental Research. 2007;31:436–442. [PubMed]
  • Kushner MG, Sher KJ, Beitman BD. The relation between alcohol problems and anxiety disorders. American Journal of Psychiatry. 1990;147:685–695. [PubMed]
  • Kuyken W, Tsivrikos D. Therapist competence, comorbidity and cognitive-behavioral therapy for depression. Psychotherapy & Psychosomatics. 2009;78:42–48. [PubMed]
  • Laaksonen E, Koski-Jannes A, Salapuro M, et al. A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence. Alcohol and Alcoholism. 2008;43:53–61. [PubMed]
  • Ladewig D, Knecht T, Leher P, et al. Acamprosate — a stabilizing factor in the long-term treatment of alcoholics. Therapeutische Umschau. 1993;50:182–188. [PubMed]
  • Lam WKK, Fals-Stewart W, Kelley ML. Parent training with behavioral couples therapy for fathers’ alcohol abuse: Effects on substance use, parental relationship, parenting and CPS involvement. Child Maltreatment. 2009;14:243–254. [PubMed]
  • Lambert MJ, Whipple JL, Vermeersch DA, et al. Enhancing psychotherapy outcomes via providing feedback on client progress: a replication. Clinical Psychology and Psychotherapy. 2002;9:91–103.
  • Landmark CJ. Targets for antiepileptic drugs in the synapse. Medical Science Monitor: International medical of Experimental and Clinical Research. 2007;13:RA1–RA7. [PubMed]
  • Lange-Asschenfeldt C, Muller MJ, Szegedi A, et al. Symptom-triggered versus 16 standard chlormethiazole treatment of inpatient alcohol withdrawal: clinical 17 implications from a chart analysis. European Addiction Research. 2003;9:1–7. [PubMed]
  • Lapham S, Forman R, Alexander M, et al. The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients. Journal of Substance Abuse Treatment. 2009;36:1–6. [PubMed]
  • Larner AJ. Addenbrooke’s Cognitive Examination-Revised (ACE-R) in day-to-day clinical practice. Age and Ageing. 2007;36:685–686. [PubMed]
  • Latendresse SJ, Rose RJ, Viken RJ, et al. Examining the etiology of associations between perceived parenting and adolescents’ alcohol use: common genetic and/or environmental liabilities? Journal of Studies on Alcohol and Drugs. 2010;71:13–25. [PMC free article] [PubMed]
  • Latt NC, Jurd S, Houseman J, et al. Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting. Medical Journal of Australia. 2002;176:530–534. [PubMed]
  • Lawford BR, Young RM, Rowell JA, et al. Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele. Nature Medicine. 1995;1:337–341. [PubMed]
  • Lechtenberg R, Worner TM. Seizure risk with recurrent alcohol detoxification. Archives of Neurology. 1990;47:535–538. [PubMed]
  • Lee A, Tan S, Lim D, et al. Naltrexone in the treatment of male alcoholics – an effectiveness study in Singapore. Drug and Alcohol Review. 2001;20:193–199.
  • Leeman RF, Palmer RS, Corbin WR, et al. A pilot study of naltrexone and BASICS for heavy drinking young adults. Addicitive Behaviors. 2008;33:1048–1054. [PMC free article] [PubMed]
  • Leggio L, Garbutt JC, Addolorato G. Effectiveness and safety of baclofen in the treatment of alcohol dependent patients. CNS & Neurological Disorders Drug Trials. 2010;9:33–34. [PubMed]
  • Leichsenring F, Rabung S, Leibing E. The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders: a meta-analysis. Archives of General Psychiatry. 2004;61:1208–1216. [PubMed]
  • Leigh G, Hodgins DC, Milne R, et al. Volunteer assistance in the treatment of chronic alcoholism. American Journal of Drug and Alcohol Abuse. 1999;25:543–559. [PubMed]
  • Lennings CJ. An evalustaion of the Leeds Dependence Questionnaire. Journal of Child & Adolescent Substance Abuse. 1999;8:73–87.
  • Leon DA, McCambridge J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data. Lancet. 2006;367:52–56. [PubMed]
  • Leontaridi R. Alcohol Misuse: How Much Does it Cost? London: Cabinet Office; 2003.
  • Lesch O, Walter H. Subtypes of alcoholism and their role in therapy. Alcohol & Alcoholism. 1996;31:63–67. [PubMed]
  • Leung A. Acupuncture treatment of withdrawal symptoms. American Journal of Acupuncture. 1977;5:43.
  • Lezak MD. Neuropsychological Assessment. 3. London: Oxford University Press; 1995.
  • Liddel J, Williamson M, Irwig L. Method for Evaluating Research and Guideline Evidence. Sydney: New South Wales Health Department; 1996.
  • Liddle HA. A multidimensional model for treating the adolescent drug abuser, Empowering Families, Helping Adolescents: Family-Centered Treatment of Adolescents with Mental Health and Substance Abuse Problems. Snyder W, Ooms T, editors. Washington, DC: U.S. Government Printing Office; 1992. pp. 91–100.
  • Ling W, Weiss DG, Charuvastra C, et al. Use of disulfiram for alcoholics in methadone maintenance programs. Archives of General Psychiatry. 1983;40:851–854. [PubMed]
  • Lishman WA. Wernicke’s Encephalopathy Organic Psychiatry. The Psychological Consequences of Cerebral Disorder. 3. Oxford: Blackwell Science; 1998.
  • Litt MD, Kadden RM, Cooney NL, et al. Coping skills and treatment outcomes in cognitive-behavioural and interactional group therapy for alcoholism. Journal of Consulting and Clinical Psychology. 2003;71:118–128. [PubMed]
  • Litt MD, Kadden RM, Kabela-Cormier E, et al. Changing network support drinking: initial findings from the network support projects. Journal of Consulting and Clinical Psychology. 2007;77:229–242. [PubMed]
  • Litt MD, Kadden RM, Kabela-Cormier E, et al. Changing network support drinking: network support project 2-year follow-up. Journal of Consulting and Clinical Psychology. 2009;75:542–555. [PMC free article] [PubMed]
  • Littleton J. Can craving be modeled in animals? The relapse prevention perspective. Addiction. 2000;95:83–90. [PubMed]
  • Liu HC, Teng EL, Lin KN, et al. Performance on a dementia screening test in relation to demographic variables. Study of 5297 community residents in Taiwan. Archives of Neurology. 1994;51:910–915. [PubMed]
  • Lock CA. Alcohol and brief intervention in primary health care: what do patients think? Primary Health Care Research and Development. 2004;5:162–178.
  • Lock CA, Kaner E, Lamont S, et al. A qualitative study of nurses’ attitudes and practices regarding brief alcohol intervention in primary health care. Journal of Advanced Nursing. 2002;39:333–342. [PubMed]
  • Loeber S, Duka T, Welzel H, et al. Impairment of cognitive abilities and decision making after chronic use of alcohol: the impact of multiple detoxifications. Alcohol & Alcoholism. 2009;44:372–381. [PubMed]
  • Longabaugh R, McCrady B, Fink E, et al. Cost effectiveness of alcoholism treatment in partial vs. inpatient settings. Journal of Studies on Alcohol. 1983;44:1049–1071. [PubMed]
  • Longabaugh R, Mattson ME, Connors GJ, et al. Quality of life as an outcome variable in alcoholism treatment research. Journal of Studies on Alcohol. 1994;(Suppl. 12):119–129. [PubMed]
  • Lozano Polo JL, Guiérrez ME, Martínez PV, et al. Effect of methadone or naltrexone on the course of transaminases in parenteral drug users with hepatitis C virus infection. Revista Clinica Espanola. 1997;197:479–483. [PubMed]
  • Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Statistics in Medicine. 2004;23:3105–3124. [PubMed]
  • Luborsky L, McLellan T, Woody G, et al. Therapist success and its determinants. Archives of General Psychiatry. 1985;42:602–611. [PubMed]
  • Luborsky L, Singer B, Luborsky L. Comparative studies of psychotherapies: is it true that “everyone has won and all must have prizes”? Archives of General Psychiatry. 1975;32:995–1008. [PubMed]
  • Lucey MR, Silverman BL, Illeperuma A, et al. Hepatic safety of once-monthly injectable extended-release naltrexone administered to actively drinking alcoholics. Alcoholism: Clinical and Experimental Research. 2008;32:498–504. [PubMed]
  • Lunn DJ, Thomas A, Best N, et al. WinBUGS – a Bayesian modelling framework: concepts, structure, and extensibility. Statistics and Computing. 2000;10:325–337.
  • Luxenberg JS, Feigenbaum LZ. Cognitive impairment on a rehabilitation service. Archives of Physical Medicine and Rehabilitation. 1986;67:796–798. [PubMed]
  • Luykx HJ, Dorresteijn LD, Haffmans PM, et al. Rivastigmine in Wernicke-Korsakoff’s syndrome: Five patients with rivastigmine showed no more improvement than five patients without rivastigmine. Alcohol and Alcoholism. 2008;43:70–72. [PubMed]
  • Macdonald J, Cartwright A, Brown G. A quantitative and qualitative exploration of client-therapist interaction and engagement in treatment in an alcohol service. Psychology and Psychotherapy: Theory, Research and Practice. 2007;80:247–268. [PubMed]
  • Maisto SA, McKay JR, Tiffany ST. Diagnosis. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2003. [23 March 2010]. Available from: http://pubs​.niaaa.nih​.gov/publications/Assesing%20Alcohol​/maisto.pdf.
  • Majumdar SK. Chlormethiazole: current status in the treatment of the acute ethanol withdrawal syndrome. Drug and Alcohol Dependence. 1990;27:201–207. [PubMed]
  • Malcolm R, Olive MF, Lechner W. The safety of disulfiram for the treatment of alcohol and cocaine dependence in randomized clinical trials: guidance for clinical practice. Expert Opinion on Drug Safety. 2008;7:459–472. [PubMed]
  • Malec TS, Malec EA, Dongier M. Efficacy of buspirone in alcohol dependence: a review. Alcoholism: Clinical and Experimental Research. 2007;20:853–858. [PubMed]
  • Mann T. Clinical Guidelines: Using Clinical Guidelines to Improve Patient Care within the NHS. London: NHS Executive; 1996.
  • Mann K. Pharmacotherapy of alcohol dependence: a review of the clinical data. CNS & Neurological Disorders Drug Trials. 2004;18:485–504. [PubMed]
  • Manikant S, Tripathi BM, Chavan BS. Loading dose diazepam therapy for alcohol 35 withdrawal state. Indian Journal of Medical Research. 1993;98:170–173. [PubMed]
  • Mark TL, Kranzler HR, Poole VH, et al. Barriers to the use of medications to treat alcoholism. American Journal of Addiction. 2003;12:281–294. [PubMed]
  • Mark TL, Kassed CA, Vandivort-Warren R, et al. Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. Drug and Alcohol Dependence. 2009;99:345–349. [PMC free article] [PubMed]
  • Markou A, Koob GF. Postcocaine anhedonia: an animal model of cocaine withdrawal. Neuropsychopharmaoclogy. 1991;4:17–26. [PubMed]
  • Marlatt GA, Gordon JR, editors. Relapse Prevention: Maintenance Strategies in the Treatment of Addiction Behaviors. New York, NY: The Guilford Press; 1985.
  • Marmot M, et al. Fair Society, Healthy Lives: Strategic Review of Health Inequalities in England post-2010. London: The Marmot Review; 2010.
  • Marques ACPR, Formigoni MLOS. Comparison of individual and group cognitive-behavioral therapy for alcohol and/or drug-dependent patients. Addiction. 2001;96:835–846. [PubMed]
  • Marsden J, Gossop G, Stewart D, et al. The Maudsley Addiction Profile (MAP): a brief instrument for assessment treatment outcome. Addiction. 1998;93:1857–1867. [PubMed]
  • Marsden J, Farrell M, Bradbury C, et al. The Treatment Outcomes Profile (TOP): A Structured Interview for the Evaluation of Substance Misuse Treatment. London: National Treatment Agency for Substance Misuse; 2007.
  • Marshall EJ, Edwards G, Taylor C. Mortality in men with drinking problems: a 20-year follow-up. Addiction. 1994;89:1293–1298. [PubMed]
  • Marshall M, Lockwood A. Early intervention for psychosis. Cochrane Database Systematic Review. 2004:CD004718. [PubMed]
  • Martin C, Kaczynski N, Maisto S, et al. Patterns of DSM–IV alcohol abuse and dependence symptoms in adolescent drinkers. Journal of Studies on Alcohol. 1995;56:672–680. [PubMed]
  • Martin DJ, Garske JP, Davis MK. Relation of the therapeutic alliance with outcome and other variables: A meta-analytic review. Journal of Consulting & Clinical Psychology. 2000;68:438–450. [PubMed]
  • Martin PR, Adinoff B, Lane E, et al. Fluvoxamine treatment of alcoholic amnestic disorder. European Neuropsychopharmacology. 1995;5:27–33. [PubMed]
  • Martinez-Raga J, Marshall EJ, Keaney F, et al. Unplanned versus planned discharges from inpatient alcohol detoxification: retrospective analysis of 270 first-episode admissions. Alcohol and Alcoholism. 2002;37:277–281. [PubMed]
  • Martinotti G, Di Nicola M, Tedeschi D, et al. Efficacy and safety of pregabalin in alcohol dependence. Advances in Therapy. 2008;25:608–618. [PubMed]
  • Martinotti G, Di Nicola M, Di Giannantonio M, et al. Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone. Journal of Psychopharmacology. 2009;23:123–129. [PubMed]
  • Mason BJ, Lehert P. The effects of current subsyndromal psychiatric symptoms or past psychopathology on alcohol dependence treatment outcomes and acamprosate efficacy. The American Journal on Addictions. 2010;19:147–154. [PubMed]
  • Mason BJ, Goodman AM, Dixon RM, et al. A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone. Neuropsychopharmacology. 2002;27:596–606. [PubMed]
  • Mason BJ, Goodman AM, Chabac S, et al. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation. Journal of Psychiatric Research. 2006;40:383–393. [PubMed]
  • Mason BJ, Light JM, Williams LD, et al. Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin. Addiction Biology. 2009;14:73–83. [PMC free article] [PubMed]
  • Mason BJ, Salvato FR, Williams LD, et al. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Archives of General Psychiatry. 1999;56:719–724. [PubMed]
  • Mathuranath PS, Nestor PJ, Berrios GE, et al. A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology. 2000;55:1613–1620. [PubMed]
  • Mattick RP, Hall W. Are detoxification programmes effective? The Lancet. 1996;347:97–100. [PubMed]
  • Mattson ME, Allen JP, Longabaugh R, et al. A chronological review of empirical studies matching alcoholic clients to treatment. Journal of Studies on Alcohol Supplement. 1994;12:16–29. [PubMed]
  • Mayer J, Filstead WJ. The Adolescent Alcohol Involvement Scale: an instrument for measuring adolescents’ use and misuse of alcohol. Journal of Studies on Alcohol. 1979;40:291–300. [PubMed]
  • Mayo-Smith MF. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. Journal of American Medical Association. 1997;278:144–151. [PubMed]
  • Mayo-Smith MF, Beecher LH, Fischer TL, et al. Management of alcohol withdrawal delirium. Archives of Internal Medicine. 2004;164:1405–1412. [PubMed]
  • McArdle P. Alcohol abuse in adolescents. Archives of Disease in Childhood. 2008;93:524–527. [PubMed]
  • McCambridge J, Day M. Randomized controlled trial of the effects of completing the Alcohol Use Disorders Identification Test questionnaire on self-reported hazardous drinking. Addiction. 2008;103:241–248. [PubMed]
  • McCance-Katz EF, Price LH, McDougle CJ, et al. Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene. Psychophramacology. 1993;111:39–46. [PubMed]
  • McCloud A, Barnaby B, Omu N, et al. Relationship between alcohol use disorders and suicidality in a psychiatric population: in-patient prevalence study. British Journal of Psychiatry. 2004;184:439–445. [PubMed]
  • McCrady BS, Epstein EE, Cook S, et al. A randomized trial of individual and couple behavioural alcohol treatment for women. Journal of Consulting and Clinical Psychology. 2009;77:243–256. [PMC free article] [PubMed]
  • McCulloch A, McMurran M. Evaluation of a treatment programme for alcohol-related aggression. Criminal Behaviour and Mental Health. 2008;18:224–231. [PubMed]
  • McGrew JG, Bond GR. Critical ingredients of assertive community treatment: judgments of the experts. The Journal of Behavioral Health Services and Research. 1995;22:113–125. [PubMed]
  • McGrew JG, Bond GR, Dietzen L, et al. Measuring the fidelity of implementation of a mental health program model. Journal of Consulting and Clinical Psychology. 1994;62:670–678. [PubMed]
  • McInnes GT. Chlormethiazole and alcohol: a lethal cocktail. British Medical Journal (Clinical Research Edition) 1987;294:592. [PMC free article] [PubMed]
  • McInnes GT, Young RE, Avery BS. Cardiac arrest following chlormethiazole infusion in chronic alcoholics. Postgraduate Medical journal. 1980;56:742–743. [PMC free article] [PubMed]
  • McKay J, Alterman A, McLellan A, et al. Effect of random versus nonrandom assignment in a comparison of inpatient and day hospital rehabilitation for male alcoholics. Journal of Consulting and Clinical Psychology. 1995;63:70–78. [PubMed]
  • McKinley MG. Alcohol withdrawal syndrome: overlooked and mismanaged? Critical Care Nurse. 2005;25:40–49. [PubMed]
  • McLachlan JFC, Stein RL. Evaluation of a day clinic for alcoholics. Journal of Studies on Alcohol. 1982;43:261–272. [PubMed]
  • McLellan AT, Luborsky L, Woody G, et al. An improved diagnostic instrument for substance abuse patients: the Addiction Severity Index. Journal of Nervous and Mental Disease. 1980;168:26–33. [PubMed]
  • McLellan AT, Luborsky L, Woody G, et al. Predicting response to alcohol and drug abuse. Medicine. 1983;15:1005–1012.
  • McLellan AT, Hagan TA, Levin M, et al. Does clinical case management improve outpatient addiction treatment. Drug and Alcohol Dependence. 1999;55:91–103. [PubMed]
  • McLellan AT, Alterman AI. Patient treatment matching: a conceptual and methodological review with suggestions for future research. NIDA Research Monograph. 1991;106:114–135. [PubMed]
  • McLellan AT, Grissom GR, Zanis D, et al. Problem-service “matching” in addiction treatment. Archives of General Psychiatry. 1997;54:730–735. [PubMed]
  • McManus S, Meltzer H, Brugha T, et al. Adult Psychiatric Morbidity in England, 2007: Results of a Household Survey. Leeds: NHS Information Centre for Health and Social Care; 2009.
  • Mee-Lee D, Shulman GD, Fishman M, et al. ASAM Patient Placement Criteria for the Treatment of Substance-Related Disorders, Second Edition – Revised (ASAM PPC-2R) Chevy Chase, MD: American Society of Addiction Medicine, Inc.; 2001.
  • Merikangas KR, Angst J, Eaton W, et al. Comorbidity and boundaries of affective disorders with anxiety disorders and substance misuse: results of an international task force. British Journal of Psychiatry. 1996;168(Suppl. 30):58–67. [PubMed]
  • Merrill J, Milner G, Owens J, et al. Alcohol and attempted suicide. British Journal of Addiction. 1992;87:83–89. [PubMed]
  • Meyers RJ, Miller WR, editors. A Community Reinforcement Approach to Addiction Treatment. Cambridge: Cambridge University Press; 2001.
  • Meyers K, McLellan AT, Jaeger JL, et al. The development of the Comprehensive Addiction Severity Index for Adolescents (CASI-A): an interview for assessing the multiple problems of adolescents. Journal of Substance Abuse Treatment. 1995;12:181–193. [PubMed]
  • Meyers RJ, Miller WR, Smith JE, et al. A randomized trial of two methods for engaging treatment-refusing drug users through concerned significant others. Journal of Consulting and Clinical Psychology. 2002;70:1182–1185. [PubMed]
  • Microsoft. Microsoft Excel [computer software] Redmond, Washington: Microsoft; 2007.
  • Miller DK, Homan SM. Determining transition probabilities: confusion and suggestions. Medical Decision Making. 1994;14:52–58. [PubMed]
  • Miller W, Benefield G, Tonigan S. Enhancing motivation for change in problem drinking: A controlled comparison of two therapist styles. Journal of Consulting and Clinical Psychology. 1993;61:455–461. [PubMed]
  • Miller WR. Motivational interviewing: research, practice and puzzles. Addictive Behaviours. 1996;21:835–842. [PubMed]
  • Miller WR, Hester RK. Inpatient alcoholism treatment. Who benefits? American Psychologist. 1986;41:794–805. [PubMed]
  • Miller WR, Marlatt GA. Manual Supplement for the Brief Drinker Profile, Follow-up Drinker Profile, and Collateral Interview Form. Odessa, FL: Psychological Assessment Resources; 1987.
  • Miller WR, Munóz R. How to Control Your Drinking. Englewood Cliffs, NJ: Prentice-Hall; 1976.
  • Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change. 2. New York, NY: Guilford Press; 2002.
  • Miller WR, Tonigan JS. Assessing drinkers’ motivation for change: the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) Psychology of Addictive Behaviors. 1996;10:81–89.
  • Miller WR, Wilbourne PL. Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction. 2002;97:265–277. [PubMed]
  • Miller WR, Zweben A, Diclemente CC, et al. Motivational Enhancement Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 1992.
  • Miller WR, Tonigan JS, Longabaugh R. The Drinker Inventory of Consequences (DrInC): An Instrument for Assessing Adverse Consequences of Alcohol Abuse. Project MATCH Monograph Series, Vol. 4. DHHS Publication No. 95-3911. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 1995.
  • Mills EJ, Wu P, Gagnier J, et al. Efficacy of acupuncture for cocaine dependence: a systematic review and meta-analysis. Harm Reduction Journal. 2005;2:4. [PMC free article] [PubMed]
  • Mioshi E, Dawson K, Mitchell J, et al. The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. International Journal of Geriatric Psychiatry. 2006;21:1078–1085. [PubMed]
  • Mohatt G, Rasmus S, Thomas L, et al. Risk, resilience, and natural recovery: a model of recovery from alcohol abuse for Alaska natives. Addiction. 2007;103:205–215. [PubMed]
  • Moncrieff J, Drummond DC, Candy B, et al. Sexual abuse in people with alcohol problems: a study of the prevalence of sexual abuse and its relationship to drinking behaviour. British Journal of Psychiatry. 1996;169:355–360. [PubMed]
  • Monteforte R, Estruch Valls-Solé J, Nicolás J, et al. Autonomic and peripheral neuropathies in patients with chronic alcoholism: a dose-related toxic effect of alcohol. Archives of Neurology. 1995;52:45–51. [PubMed]
  • Monterosso JR, Flannery BA, Pettinati HM, et al. Predicting treatment response to naltrexone: the influence of craving and family history. American Journal on Addictions. 2001;10:258–268. [PubMed]
  • Monti P, Colby S, Barnett NP, et al. Brief interventions for harm reduction with alcohol–positive older adolescents in a hospital emergency department. Journal of Consulting and Clinical Psychology. 1999;67:989–994. [PubMed]
  • Monti PM, Abrams DB, Binkoff JA, et al. Communication skills training, communication skills training with family and cognitive behavioral mood management training for alcoholics. Journal of Studies on Alcohol. 1990;51:263–270. [PubMed]
  • Monti PM, Rohsenow DJ, Rubonis AV, et al. Cue exposure with coping skills treatment for alcoholics: a preliminary investigation. Journal of Consulting and Clinical Psychology. 1993;61:1011–1019. [PubMed]
  • Monti PM, Rohsenow DJ, Swift RM, et al. Naltrexone and cue exposure with coping skills training for alcoholics: Treatment process and 1-year outcomes. Alcohol: Clinical and Experimental Research. 2001;25:1634–1647. [PubMed]
  • Moos RH, Moos BS, Andrassy JM. Outcomes of four treatment approaches in community residential programs for patients with substance use disorders. Psychiatric Services. 1999;50:1577–1583. [PubMed]
  • Moos R, Schaefer J, Andrassy J, et al. Outpatient mental health care, self-help groups, and patients’ one-year treatment outcomes. Journal of Clinical Psychology. 2001;57:273–287. [PubMed]
  • Morgan MY, Ritson EB. Alcohol and Health. 5. London: The Medical Council on Alcohol; 2009.
  • Morgenstern J, Bux DA, Labouvie E, et al. Examining mechanisms of action in 12-step community outpatient treatment. Drug and Alcohol Dependence. 2003;72:237–247. [PubMed]
  • Morgenstern J, Irwin TW, Wainberg ML, et al. A randomized controlled trial of goal choice interventions for alcohol use disorders among men who have sex with men. Journal of Consulting and Clinical Psychology. 2007;75:72–84. [PubMed]
  • Moriarty K, Cassidy P, Dalton D, et al. Alcohol-related disease. meeting the challenge of improved quality of care and better use of resources. A joint position paper on behalf of the British Society of Gastroenterology, Alcohol Health Alliance UK and the British Association for the Study of the Liver. Paper 9 C. London: British Society of Gastroenterology; Mar 31, 2010.
  • Morjaria A, Orford J. The role of religion and spirituality in recovery from drink problems: a qualititative study of Alcoholics Anonymous members and South Asian men. Addiction Research & Theory. 2002;10:225–256.
  • Morley KC, Teesson M, Reid SC, et al. Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial. Addiction. 2006;101:1451–1462. [PubMed]
  • Morris PLP, Hopwood M, Whelan G, et al. Naltrexone for alcohol dependence: a randomized controlled trial. Addiction. 2001;96:1565–1573. [PubMed]
  • Mortimer D, Segal L. Economic evaluation of interventions for problem drinking and alcohol dependence: Cost per QALY estimates. Alcohol & Alcoholism. 2005;40:549–555. [PubMed]
  • Mosher V, Davis J, Mulligan D, et al. Comparison of outcome in a 9-day and 30-day alcoholism treatment program. Journal of Studies on Alcohol. 1975;36:1277–1281. [PubMed]
  • Moyer A, Finney JW, Elworth JT, et al. Can methodological features account for patient-treatment matching findings in the alcohol field? Journal of Studies on Alcohol & Drugs. 2000;62:62–73. [PubMed]
  • Moyer A, Finney JW, Swearingen CE, et al. Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction. 2002;97:279–292. [PubMed]
  • Mueller TI, Pagano ME, Rodriguez BF, et al. Long-term use of benzodiazepines in participants with comorbid anxiety and alcohol use disorders. Alcohol: Clinical & Experimental Research. 2005;29:1411–1418. [PMC free article] [PubMed]
  • Murphy CM, Winters J, O’Farrell TJ, et al. Alcohol consumption and intimate partner violence by alcoholic men: comparing violent and non violent conflicts. Psychology of Addictive Behaviours. 2005;19:35–42. [PubMed]
  • Murray BL. Perceptions of adolescents living with parental alcoholism. Journal of Psychiatric and Mental Health Nursing. 1998;5:525–534. [PubMed]
  • Naik P, Lawton J. Assessment and management of individuals under the influence of alcohol is police custody. Journal of Clinical Forensic Medicine. 1996;3:37–44. [PubMed]
  • Najavits LM, Weiss RD. Variations in therapist effectiveness in the treatment of patients with substance use disorders: an empirical review. Addiction. 1994;89:679–688. [PubMed]
  • Namkoong K, Lee B, Lee P, et al. Acamprosate in Korean alcohol-dependent patients: a multicentre, randomized, double-blind, placebo-controlled study. Alcohol and Alcoholism. 2003;38:135–141. [PubMed]
  • Naranjo CA, Dongier M, Bremner KE. Long-acting injectable bromocriptine does not reduce relapse in alcoholics. Addiction. 1997;92:969–978. [PubMed]
  • National Audit Office. Reducing Alcohol Harm: Health Services in England for Alcohol Misuse. London: National Audit Office; 2008.
  • National Institute on Alcohol Abuse and Alcoholism. Estimating the Economic Cost of Alcohol Abuse. No. 11 PH 293. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 1991. [May 2010]. Available from:http://pubs​.niaaa.nih​.gov/publications/aa11.htm.
  • National Treatment Agency. National Alcohol Treatment Monitoring System. 2009. [7 January 2010]. Available from: http://www​.alcohollearningcentre​​/Latest/Resource/?cid=5120.
  • National Treatment Agency. Residential Drug Treatment Services: A Summary of Good Practice. London: National Treatment Agency; 2009.
  • National Treatment Agency and Department of Health. Statistics from the National Alcohol Treatment Monitoring System (NATMS) 1st April 2008 – 31st March 2009. London: Department of Health; 2010.
  • National Treatment Agency for Substance Misuse. Models of Care for Treatment of Adult Drug Misusers: Promoting Quality, Efficiency and Effectiveness in Drug Misuse Treatment Services in England. Part 2: Full Reference Report. London: National Treatment Agency for Substance Misuse; 2002.
  • National Treatment Agency for Substance Misuse. Models of Residential Rehabilitation for Drug and Alcohol Misusers. London: National Treatment Agency; 2006.
  • National Treatment Agency for Substance Misuse. Drug Misuse and Dependence: Guidelines on Clinical Management. London: National Treatment Agency for Substance Misuse; 2007.
  • National Treatment Agency for Substance Misuse. Treatment Outcomes Profile (TOP). The Protocol for Reporting TOP: a Keyworkers Guide. London: National Treatment Agency for Substance Misuse; 2010.
  • NCCMH. Post-Traumatic Stress Disorder (PTSD): The Management of PTSD in Adults and Children in Primary and Secondary Care. Leicester & London: The British Psychological Society & The Royal College of Psychiatrists; 2005. (National Clinical Practice Guideline Number 26).
  • NCCMH. Drug Misuse: Psychosocial Interventions. Leicester & London: The British Psychological Society & The Royal College of Psychiatrists; 2008. (National Clinical Practice Guideline Number 51).
  • NCCMH. Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults. Leicester & London: The British Psychological Society & The Royal College of Psychiatrists; 2009. (National Clinical Practice Guideline Number 72).
  • Nelson A, Fogel BS, Faust D. Bedside cognitive screening instruments. A critical assessment. Journal of Nervous and Mental Disease. 1986;174:73–83. [PubMed]
  • Nelson-Zlupko L, Morrison-Dore M, Kauffman E. Women in recovery: Their perceptions of treatment effectiveness. Journal of Substance Abuse Treatment. 1996;13:51–59. [PubMed]
  • NHS Employers. Clinical Directed Enhanced Services (DES) Guidance for GMS Contract 2008/09: Delivering Investment in General Practice. London: NHS Employers; 2008. [May 2010]. Available from: http://www​.alcoholpolicy​.net/files/clinical​_directed_enhanced_services.pdf.
  • NHS Information Centre & National Statistics. Statistics on Drug Misuse: England 2009. London: The Health and Social Care Information Centre; 2009. [4 February 2011]. Available from: http://www​​/webfiles/publications​/drugmisuse09/Statistics​_on_Drug_Misuse​_England_2009_revised.pdf.
  • Niaura RS, Rohsenow DJ, Binkoff JA, et al. The relevance of cue reactivity to understanding alcohol and smoking relapse. Journal of Abnormal Psychology. 1988;97:133–152. [PubMed]
  • NICE. Anxiety: Management of Anxiety (Panic Disorder, with or without Agoraphobia, and Generalised Anxiety Disorder) in Adults in Primary, Secondary and Community Care. London: NICE; 2004. (Clinical Guideline 22). [PubMed]
  • NICE. Obsessive Compulsive Disorder (OCD) and Body Dysmorphic Disorder (BDD): Core Interventions in the Treatment of Obsessive-Compulsive Disorder and Body Dysmorphic Disorder. London: National Institute for Clinical Excellence; 2006. (Clinical Guideline 31).
  • NICE. Brief Interventions and Referral for Smoking Cessation in Primary Care and Other Settings. London: NICE; 2006. (Public Health Intervention Guidance No. 1).
  • NICE. Drug Misuse: Psychosocial Interventions. London: NICE; 2007. (Clinical Guideline 51).
  • NICE. Drug Misuse: Opioid Detoxification. London: NICE; 2007. (Clinical Guideline 52).
  • NICE. Community-Based Interventions to Reduce Substance Misuse Among Vulnerable and Disadvantaged Children and Young People. London: NICE; 2007. (Public Health Intervention Guidance No. 4).
  • NICE. Antisocial Personality Disorder: Treatment, Management and Prevention. London: National Institute for Clinical Excellence; 2008. (Clinical Guideline 77).
  • NICE. Social Value Judgements Principles for the Development of NICE Guidance. 2. London: NICE; 2008.
  • NICE. The Guidelines Manual. London: NICE; 2009.
  • NICE. Depression: The Treatment and Management of Depression in Adults. London: NICE; 2009. (Clinical Guideline 90).
  • NICE. Alcohol-Use Disorders: Preventing the Development of Hazardous and Harmful Drinking. London: NICE; 2010. (Public Health Intervention Guidance No. 24).
  • NICE. Alcohol-Use Disorders: Diagnosis and Clinical Management of Alcohol-Related Physical Complications. London: NICE; 2010. (Clinical Guideline 100). [PubMed]
  • NICE. Pregnancy and Complex Social Factors: A Model for Service Provision for Pregnant Women with Complex Social Factors. London: NICE; 2010. (Clinical Guideline 110). [PubMed]
  • NICE. Psychosis with Coexisting Substance Misuse: Assessment and Management in Adults and Young People. London: NICE; 2011. (Clinical Guideline 120). [PubMed]
  • NICE. Common Mental Health Disorders: Identification and Pathways to Care. London: NICE; 2011. (Clinical Guideline 123).
  • NICE. Generalised Anxiety Disorder and Panic Disorder (With or Without Agoraphobia) in Adults: Management in Primary, Secondary and Community Care. London: NICE; 2011. (Clinical Guideline 113).
  • Niederhofer H, Staffen W. Acamprosate and its efficacy in treating alcohol dependent adolescents. European Child and Adolescent Psychiatry. 2003;12:144–148. [PubMed]
  • Niederhofer H, Staffen W. Comparison of disulfiram and placebo in treatment of alcohol dependence in adolescents. Drug and Alcohol Review. 2003;22:295–297. [PubMed]
  • Niederhofer H, Staffen W, Mair A. Comparison of naltrexone and placebo in treatment of alcohol dependence of adolescents. Alcoholism Treatment Quarterly. 2003;21:87–95.
  • Nielsen AS. Alcohol problems and treatment: the patients’ perceptions. European Addiction Research. 2003;9:29–38. [PubMed]
  • Nordqvist C, Johansson K, Bendtsen P. Routine screening for risky alcohol consumption at an emergency department using the AUDIT-C questionnaire. Drug and Alcohol Dependence. 2004;74:71–75. [PubMed]
  • North West Public Health Observatory. Local Alcohol Profiles for England. 2010. [5 October 2010]. Available from: http://www​
  • Nowinski J, Baker S, Carroll K. Twelve Step Facilitation Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence. Washington, DC: Government Printing Office; 1992. NIAAA Project MATCH Monograph, Vol 1, DHHS Publication No. (ADM) 92-1893.
  • Nunnally J. Psychometric Theory. New York: McGraw-Hill; 1978.
  • Nunes EV, Levin FR. Treatment of Depression in Patients with alcohol or other drug dependence. Journal of the American Medical Association. 2004;291:1887–1896. [PubMed]
  • Nutt D. Alcohol and the brain. Pharmacological insights for psychiatrists. The British Journal of Psychiatry. 1999;175:114–119. [PubMed]
  • NVivo. NVivo qualitative data analysis software. Version 9. Victoria, Australia: QSR International Pty Ltd.; 2010.
  • O’Connell H, Chin AC, Cunningham C, et al. Alcohol use disorders in elderly people: redefining and age old problem in old age. British Medical Journal. 2003;327:664–667. [PMC free article] [PubMed]
  • O’Connor PG, Schottenfeld RS. Patients with alcohol problems. The New England Journal of Medicine. 1998;338:592–602. [PubMed]
  • O’Connor PG, Gottlieb LD, Kraus ML, et al. Social and clinical features as predictors of outcomes in outpatient alcohol withdrawal. Journal of General Internal Medicine. 1991;6:312–316. [PubMed]
  • O’Connor PG, Samet JH, Stein MD. Management of hospitalized intravenous drug users: role of the internist. American Journal of Medicine. 1994;96:551–558. [PubMed]
  • O’Donnell WE, Reynolds D McQ. Neuropsychological Impairment Scale (NIS) Manual. Annapolis, MD: Annapolis Neuropsychological Services; 1983.
  • O’Donnell WE, DeSoto CB, Reynolds D McQ. Sensitivity and specificity of the Neuropsychological Impairment Scale (NIS) Journal of Clinical Psychology. 1984;40:553–555. [PubMed]
  • O’Donnell WE, Reynolds DQ, de Soto CB. Neuropsychological impairment scale (NIS): initial validation study using trailmaking test (A & B) and WAIS digit symbol (scaled score) in a mixed grouping of psychiatric, neurological, and normal patients. Journal of Clinical Psychology. 1984;39:746–748. [PubMed]
  • O’Farrell TJ, Cutter HSG, Choquette KA, et al. Behavioral marital therapy for male alcoholics: marital and drinking adjustment during the two years after treatment. Behavior Therapy. 1992;23:529–549.
  • O’Hare T, Sherrer M, LaButti A, et al. Validating the Alcohol Use Disorders Identification Test in persons who have serious mental illness. Research on Social Work Practice. 2006;14:36–42.
  • O’Malley S. Naltrexone and Alcoholism Treatment 28: Treatment Improvement Protocol (TIP) Series 28. Rockville, MD: Substance Abuse and Mental Health Services Administration (US); 1993. [May 2010]. (Chair) Available from: http://www​.ncbi.nlm.nih​.gov/bookshelf/br​.fcgi?book=hssamhsatip&part​=A51510.
  • O’Malley SS, Jaffe AJ, Chang G, et al. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Archives of General Psychiatry. 1992;49:881–887. [PubMed]
  • O’Malley SS, Jaffe AJ, Rode S, et al. Experience of a ‘slip’ among alcoholics treated with naltrexone or placebo. American Journal of Psychiatry. 1996;153:281–283. [PubMed]
  • O’Malley KD, Nanson J. Clinical implications of a link between fetal alcohol spectrum disorder and attention-deficit hyperactivity disorder. Canadian Journal of Psychiatry. 2002;47:349–354. [PubMed]
  • O’Malley SS, Rounsaville BJ, Farren C, et al. Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs. specialty care. Archives of Internal Medicine. 2003;163:1695–1704. [PubMed]
  • O’Malley SS, Robin RW, Levenson AL, et al. Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and natives residing in rural settings: a randomized controlled trial. Alcoholism: Clinical and Experimental Research. 2008;32:1271–1283. [PMC free article] [PubMed]
  • Office for National Statistics. Alcohol-Related Death Rates in England and Wales, 2001–2003. London: Office for National Statistics; 2003.
  • Ofori-Adjei D, Casswell S, Drummond C, et al. World Health Organization Expert Committee on Problems Related to Alcohol Consumption, Second Report. Geneva: WHO; 2007.
  • Okiishi J, Lambert MJ, Nielsen SL, et al. Waiting for supershrink: an empirical analysis of therapist effects. Clinical Psychology and Psychotherapy. 2003;10:361–373.
  • Ojehagen A, Berglund M, Hansson L. The relationship between helping alliance and outcome in outpatient treatment of alcoholics: a comparative study of psychiatric treatment and multimodal behavioural therapy. Alcohol and Alcoholism. 1997;32:241–249. [PubMed]
  • Olive MF. Metabotropic glutamate receptor ligands as potential therapeutics for addiction. Current Drug Abuse Reviews. 2009;2:83–989. [PMC free article] [PubMed]
  • Omer H, Foldes J, Toby M, et al. Screening for cognitive deficits in a sample of hospitalized geriatric patients. a re-evaluation of a brief mental status questionnaire. Journal of the American Geriatrics Society. 1983;31:266–268. [PubMed]
  • Ooteman W, Naassila M, Koeter MWJ. Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators. Addiction Biology. 2009;14:328–337. [PubMed]
  • Orford J, Oppenheimer E, Edwards G. Abstinence or control: the outcome for excessive drinkers two years after consultation. Behaviour Research and Therapy. 1976;14:409–418. [PubMed]
  • Orford J, Natera G, Davies J, et al. Tolerate, engage or withdraw: a study of the structures of families coping with alcohol and drug problems in South West England and Mexico City. Addiction. 1998;93:1799–1813. [PubMed]
  • Orford J, Natera G, Davies J, et al. Social support in coping with alcohol and drug problems at home: findings from Mexican and English families. Addiction Research & Theory. 1998;6:395–420.
  • Orford J, Dalton S, Hartney E, et al. The close relatives of untreated heavy drinkers: perspectives on heavy drinking and its effects. Addiction Research and Theory. 2002;10:439–463.
  • Orford J, Natera G, Copello A, et al. Coping with Alcohol and Drug Problems: The Experiences of Family Members in Three Contrasting Cultures. London: Taylor and Francis; 2005.
  • Orford J, Hodgson R, Copello A, et al. The clients’ perspective on change during treatment for an alcohol problem: qualitative analysis of follow-up interviews in the UK Alcohol Treatment Trial. Addiction. 2006;101:60–68. [PubMed]
  • Orford J, Korr C, Copello A, et al. Why people enter treatment for alcohol problems: findings from UK Alcohol Treatment Trial. Addiction. 2006;101:60–68. [PubMed]
  • Orford J, Hodgson R, Copello A, et al. To what factors do clients attribute change? Content analysis of follow-up interviews with clients of the UK Alcohol Treatment Trial. Journal of Substance Abuse Treatment. 2008;36:49–58. [PubMed]
  • Oroszi G, Anton RF, O’Malley S, et al. OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach. Alcoholism: Clinical & Experimental Research. 2009;33:383–393. [PMC free article] [PubMed]
  • Oslin D, Liberto JG, O’Brien J, et al. Naltrexone as an adjunctive treatment for older patients with alcohol dependence. The American Journal of Geriatric Psychiatry. 1997;5:324–332. [PubMed]
  • Oslin DW, Cary MS. Alcohol-related dementia: validation of diagnostic criteria. American Journal of Geriatric Psychiatry. 2003;11:441–447. [PubMed]
  • Oslin DW, Berrettini W, Kranzler HR, et al. A functional polymorphism of the μ -opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology. 2003;28:1546–1552. [PubMed]
  • Oslin DW, Lynch KG, Pettinati HM, et al. A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial education. Alcoholism: Clinical and Experimental Research. 2008;32:1299–1308. [PMC free article] [PubMed]
  • Oswald LM, Wand GS. Opioids and alcoholism. Physiology & Behavior. 2004;81:339–358. [PubMed]
  • Owens D, Horrocks J, House A. Fatal and non-fatal repetition of self-harm. British Journal of Psychiatry. 2002;181:193–199. [PubMed]
  • Paille FM, Guelfi JD, Perkins AC, et al. Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol and Alcoholism. 1995;30:239–247. [PubMed]
  • Palmer AJ, Neeser K, Weiss C, et al. The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate. Alcohol and Alcoholism. 2000;35:478–492. [PubMed]
  • Pani PP, Trogu E, Vacca R, et al. Disulfiram for the treatment of cocaine dependence. Cochrane Database of Systematic Reviews. 2010;20:CD007024. [PubMed]
  • Parrott S, Godfrey C, Heather N, et al. Cost and outcome analysis of two alcohol detoxification services. Alcohol and Alcoholism. 2006;41:84–91. [PubMed]
  • Passetti F, Jones G, Chawla K, et al. Pilot study of assertive community treatment methods to engage alcohol-dependent individuals. Alcohol and Alcoholism. 2008;43:451–455. [PubMed]
  • Patterson DG, Macpherson J, Brady NM. Community psychiatric nurse aftercare for alcoholics: a five-year follow-up study. Addiction. 1997;92:459–468. [PubMed]
  • Pelc I, Le Bon O, Verbanck, et al. Calcium acetyl homotaurinate for maintaining abstinence in weaned alcoholic patients; a placebo controlled double-blind multi-centre study, Novel Pharmacological Interventions for Alcoholism. Naranjo C, Sellers E, editors. New York, NY: Springer Verlag; 1992. pp. 348–352.
  • Pelc I, Verbanck P, Le Bon O, et al. Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. British Journal of Psychiatry. 1997;171:73–77. [PubMed]
  • Pennings EJM, Leccese AP, de Wolff FA. Effects of concurrent use of alcohol and cocaine. Addiction. 2002;97:773–783. [PubMed]
  • Perepletchikova F, Krystal JH, Kaufman J. Practitioner review: adolescent alcohol use disorders: assessment and treatment issues. Journal of Child Psychology and Psychiatry. 2008;49:1131–1154. [PMC free article] [PubMed]
  • Petrakis I, Ralevski E, Nich C, et al. Naltrexone and DIS in patients with alcohol dependence and current depression. Journal of Clinical Psychopharmacology. 2007;27:160–165. [PubMed]
  • Petrakis IL, Carroll KM, Nich C, et al. Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. Addiction. 2000;95:219–228. [PubMed]
  • Petrakis IL, Gonzalez G, Rosenheck R, et al. Comorbidity of alcoholism and psychiatric disorders : an overview. Alcohol Research & Health. 2002;26:81–89.
  • Petrakis IL, Poling J, Levinson C, et al. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. BiologicalPsychiatry. 2005;57:1128–1137. [PubMed]
  • Petrakis IL, Leslie D, Finney JW, et al. Atypical antipsychotic medication and substance use – related outcomes in the treatment of schizophrenia. American Journal on Addiction. 2006;15:44–49. [PubMed]
  • Petry NM, Martin B, Cooney JL, et al. Give them prizes, and they will come: Contingency management for treatment of alcohol dependence. Journal of Consulting and Clinical Psychology. 2000;68:250–257. [PubMed]
  • Pettinati HM, Meyers K, Jensen JM, et al. Inpatient vs. outpatient treatment for substance dependence revisited. Psychiatric Quarterly. 1993;64:173–182. [PubMed]
  • Pettinati HM, Meyers K, Evans BD, et al. Inpatient alcohol treatment in a private healthcare setting: which patients benefit and at what cost? The American Journal on Addictions. 1999;8:220–233. [PubMed]
  • Pettinati HM, Volpicelli JR, Kranzler HR, et al. Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcoholism: Clinical and Experimental Research. 2000;24:1041–1049. [PubMed]
  • Pettinati HM, Kampman KM, Lynch KG, et al. A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence. Addictive Behaviors. 2008;33:651–667. [PMC free article] [PubMed]
  • Pettinati HM, Kampman KM, Lynch KG, et al. Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence. Journal of Substance Abuse Treatment. 2008;34:378–390. [PMC free article] [PubMed]
  • Pettinati HM, Oslin DW, Kampman KM, et al. A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. The American Journal of Psychiatry. 2010;167:668–675. [PMC free article] [PubMed]
  • Piacentini J, Shaffer D, Fisher P, et al. The Diagnostic Interview Schedule for Children-Revised version (DISC-R): III. Concurrent criterion validity. Journal of the American Academy of Child and Adolescent Psychiatry. 1993;32:658–665. [PubMed]
  • Pittman DJ, Tate RL. A comparison of two treatment programs for alcoholics. Journal of Social Psychiatry. 1972;18:183–193. [PubMed]
  • Poldrugo F. Acamprosate treatment in a long-term community-based alcohol rehabilitation program. Addiction. 1997;92:1537–1546. [PubMed]
  • Poulsen HE, Loft S, Andersen JR, et al. Disulfiram therapy – adverse drug reactions and interactions. Acta Psychiatrica Scandinavica. 1992;369:59–65. [PubMed]
  • Pragst F, Balikova MA. State of the art in hair analysis for detection of drug and alcohol abuse. Clinica Chimica Acta. 2006;370:17–49. [PubMed]
  • Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Annals of Internal Medicine. 2002;137:1–10. [PubMed]
  • Prendergast M, Podus D, Finney J, et al. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction. 2006;101:1546–1560. [PubMed]
  • Prime Minister’s Strategy Unit. Strategy Unit Alcohol Harm Reduction Project Interim Analytic Report. London: Cabinet Office; 2003.
  • Prime Minister’s Strategy Unit. Alcohol Harm Reduction Strategy. London: Cabinet Office; 2004.
  • Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. Journal of Consulting and Clinical Psychology. 1983;51:390–395. [PubMed]
  • Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. Journal of Consulting and Clinical Psychology. 2004;72:1144–1156. [PubMed]
  • Project MATCH Research Group. Project MATCH: rationale and methods for a multisite clinical trial matching patients to alcoholism treatment. Alcoholism: Clinical and Experimental Research. 1993;17:1130–1145. [PubMed]
  • Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol. 1997;58:7–29. [PubMed]
  • Project MATCH Research Group. Therapist effects in three treatments for alcohol problems. Psychotherapy Research. 1998;8:455–474.
  • Qatari M, Shabeena K, Barton H, et al. Acamprosate is neuroprotective against glutamate-induced excitotoxicity when enhanced by ethanol withdrawal in neocortical cultures of fetal rat brain. Alcoholism: Clinical and Experimental Research. 2001;25:1276–1283. [PubMed]
  • Raistrick D, Tober G. Much more than outcomes. Drug & Alcohol Findings. 2003;8:27–29.
  • Raistrick D, Dunbar G, Davidson R. Development of a questionnaire to measure alcohol dependence. Addiction. 1983;78:89–95. [PubMed]
  • Raistrick D, Bradshaw J, Tober G, et al. Development of the Leeds Dependence Questionnaire (LDQ): a questionnaire to measure alcohol and opiate dependence in the context of a treatment evaluation package. Addiction. 1994;89:563–572. [PubMed]
  • Raistrick D, Heather N, Godfrey C. Review of the Effectiveness of Treatment for Alcohol Problems. London: National Treatment Agency for Substance Misuse; 2006.
  • Ramayya A, Jauhar P. Increasing incidence of Korsakoff’s psychosis in the East End of Glasgow. Alcohol & Alcoholism. 1997;32:281–285. [PubMed]
  • Rampes H, Pereira S, Mortimer A, et al. Does electroacupuncture reduce craving for alcohol? A randomized controlled study. Complementary Therapies in Medicine. 1997;5:19–26.
  • Ramsay M, editor. Prisoners’ Drug Use and Treatment: Seven Research Studies. London: Home Office Research, Development and Statistics Directorate, HMSO; 2003. Home Office Research Study 267.
  • Randall CL, Johnson MR, Thevos AK, et al. Paroxetine for social anxiety and alcohol use in dual-diagnosed patients. Depression and Anxiety. 2001;14:255–262. [PubMed]
  • Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the epidemiologic catchment area (ECA) study. Journal of the American Medical Association. 1990;264:2511–2518. [PubMed]
  • Rehm R, Room K, Graham M, et al. The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease – an overview. Addiction. 2003;98:1209–1228. [PubMed]
  • Rehm J, Room R, Monteiro M, et al. Alcohol use, Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Ezzati M, Lopez AD, Rodgers A, et al., editors. Geneva: WHO; 2004.
  • Rehm J, Ballunas D, Brochu S, et al. The Costs of Substance Abuse in Canada 2002. Ottawa: Canadian Centre on Substance Abuse; 2006.
  • Rehm J, Mathers C, Popova S, et al. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373:2223–2233. [PubMed]
  • Reid MC, Anderson PA. Geriatric substance use disorders. Medical Clinics of North America. 1997;81:999–1016. [PubMed]
  • Reinert DF, Allen JP. The Alcohol Use Disorders Identification Test: an update of research findings alcoholism. Clinical and Experimental Research. 2007;31:185–199. [PubMed]
  • Reoux JP, Miller K. Routine hospital alcohol detoxification practice compared to 24 symptom triggered management with an Objective Withdrawal Scale (CIWA-Ar) American Journal on Addictions. 2000;9:135–144. [PubMed]
  • Reuster T, Buechler J, Winiecki P, et al. Influence of reboxetine on salivary MHPG concentration and cognitive symptoms among patients with alcohol-related Korsakoff’s syndrome. Neuropsychopharmacology. 2003;28:974–978. [PubMed]
  • Richardson K, Baillie A, Reid S, et al. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol? Addiction. 2008;103:953–959. [PubMed]
  • Robins LN, Wing J, Wittchen HU, et al. The Composite International Diagnostic Interview: an epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Archives of General Psychiatry. 1989;45:1069–1077. [PubMed]
  • Robinson TE, Berridge KC. Review. The incentive sensitization theory of addiction: some current issues. Philosophical Transactions of the Royal Society of London (Series B) Biological Sciences. 2008;363:3137–3146. [PMC free article] [PubMed]
  • Robinson S, Bulger C. General Lifestyle Survey 2008: Smoking and Drinking Among Adults, 2008. Newport: Office for National Statistics; 2010.
  • Rogers CR. Client-Centered Therapy; Its Current Practice, Implications, and Theory. Oxford: Houghton Miffin; 1951.
  • Rohsenow DJ, Monti PM, Hutchinson KE, et al. Naltrexone’s effects on reactivity to alcohol cues among alcoholic men. Journal of Abnormal Psychology. 2000;109:738–742. [PubMed]
  • Rolfe A, Dalton S, Orford J. On the road to Damascus? A qualitative study of life events and decreased drinking. Contemporary Drug Problems. 2005;32:589–603.
  • Rolfe A, Orford J, Dalton S, et al. Women, alcohol and femininity: a discourse analysis of women heavy drinkers’ accounts. Journal of Health Psychology. 2009;14:326–335. [PubMed]
  • Rollnick S, Heather N, Gold R, et al. Development of a short ‘readiness to change’ questionnaire for use in brief, opportunistic interventions among excessive drinkers. British Journal of Addiction. 1992;87:743–754. [PubMed]
  • Rollnick S, Mason P, Butler C. Health Behavior Change: A Guide for Practitioners. Edinburgh: Churchill Livingstone; 1999.
  • Room R, Babor T, Rehm J. Alcohol and public health. Lancet. 2005;365:519–530. [PubMed]
  • Rosenblum A, Cleland C, Magura S, et al. Moderators of effects of motivational enhancements to cognitive behavioural therapy. The American Journal of Drug and Alcohol Abuse. 2005;1:35–58. [PubMed]
  • Rosenblum A, Magura S, Kayman DJ, et al. Motivationally enhanced group counselling for substance users in a soup kitchen: a randomized clinical trial. Drug and Alcohol Dependence. 2005;80:91–103. [PubMed]
  • Rosner S, Leucht S, Lehert P, et al. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes. Journal of Psychopharmacology. 2008;22:11–23. [PubMed]
  • Roth AD, Pilling S. Using an evidence-based methodology to identify the competences required to deliver effective cognitive and behavioural therapy for depression and anxiety disorders. Behavioural and Cognitive Psychotherapy. 2008;36:129–147.
  • Roth AD, Pilling S. The impact of adherence and competence on outcome in CBT and psychological therapies. 2011. In preparation.
  • Roth AD, Pilling S, Turner J. Therapist training and supervision in clinical trials: Implications for clinical practice. Behavioural and Cognitive Psychotherapy. 2010;38:291–302. [PubMed]
  • Roussaux JP, Hers D, Ferauge M. Does acamprosate diminish the appetite for alcohol in weaned alcoholics? Journal de Pharmacie de Belgique. 1996;51:65–68. [PubMed]
  • Royal College of Physicians. Alcohol: Can the NHS Afford It? London: Royal College of Physicians; 2001.
  • Royal College of Psychiatrists. Alcohol: Our Favourite Drug. London: Royal College of Psychiatrists; 1986.
  • Rubio G, Jiminez-Arriero MA, Ponce G, et al. Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment. Alcohol and Alcoholism. 2001;36:419–425. [PubMed]
  • Rubio G, Ponce G, Rodriguez-Jiménez R, et al. Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone? Alcohol and Alcoholism. 2005;40:227–233. [PubMed]
  • Rush B. A systems approach to estimating the required capacity of alcohol treatment services. British Journal of Addiction. 1990;85:49–59. [PubMed]
  • Russell M, Marshall JR, Trevisan M, et al. Test-retest reliability of the Cognitive Lifetime Drinking History. American Journal of Epidemiology. 1997;146:975–981. [PubMed]
  • Ryan L, Ottlinger A. Implementation of alcohol withdrawal program in a medical-setting: improving patient outcomes. Journal of Addictions Nursing. 1999;11:102–106.
  • Rychtarik RG, Connors GJ, Whitney RB, et al. Treatment settings for persons with alcoholism: evidence for matching clients to inpatient versus outpatient care. Journal of Consulting and Clinical Psychology. 2000;68:277–289. [PubMed]
  • Rychlik R, Siedentop H, Pfiel T, et al. Cost-effectiveness of adjuvant treatment with acamprosate in maintaining abstinence in alcohol dependent patients. European Addiction Research. 2003;9:59–64. [PubMed]
  • Sacks L. Drug addiction, alcoholism, smoking, obesity, treated by auricular acupuncture. American Journal of Acupuncture. 1975;3:147–150.
  • Sacks S, Sacks JY, McKendrick K, et al. Modified TC for MICA inmates in correctional settings: crime outcomes. Behavioural Sciences and the Law. 2004;22:477–501. [PubMed]
  • Saitz R, Mayo-Smith MF, Roberts MS, et al. Individualized treatment for alcohol 13 withdrawal: a randomised double- blind controlled trial. Journal of the American Medical Association. 1994;272:519–523. [PubMed]
  • Saitz R, O’Malley SS. Pharmacotherapies for alcohol abuse. Alcohol and Other Substance Abuse. 1997;4:881–907. [PubMed]
  • Sandahl C, Herlitz K, Ahlin G, et al. Time-limited group psychotherapy for moderately alcohol dependent patients: a randomized controlled clinical trial. Psychotherapy Research. 1998;8:361–378.
  • Sannibale C, Hurkett P, van den Bossche E, et al. Aftercare attendance and post-treatment functioning of severely substance dependent residential treatment clients. Drug and Alcohol Review. 2003;22:181–190. [PubMed]
  • Santis R, Garmendia M, Acuña G, et al. The Alcohol Use Disorders Identification Test (AUDIT) as a screening instrument for adolescents. Drug and Alcohol Dependence. 2009;103:155–157. [PubMed]
  • Specialist Clinical Addiction Network. Inpatient Treatment of Drug and Alcohol Misusers in the National Health Service. London: SCAN; 2006.
  • Sass H, Soyka M, Mann K, et al. Relapse prevention by acamprosate. Archives of General Psychiatry. 1996;53:673–680. [PubMed]
  • Schadé A, Marquenie LA, van Balkom AJLM, et al. The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomized controlled trial. Alcoholism: Clinical and Experimental Research. 2005;29:794–800. [PubMed]
  • Schadlich PK, Brecht JG. The cost effectiveness of acamprosate in the treatment of alcoholism in Germany. Economic evaluation of the Prevention of Relapse with Acamprosate in the Management of Alcoholism (PRAMA) study. PharmacoEconomics. 1998;13:719–730. [PubMed]
  • Schmidt A, Barry KL, Fleming MF. Detection of problem drinkers: the Alcohol Use Disorders Identification Test (AUDIT) Southern Medical Journal. 1995;J88:52–59. [PubMed]
  • Schmitz JM, Averill P, Sayre S, et al. Cognitive–behavioral treatment of bipolar disorder and substance abuse: preliminary randomized study. Addictive Disorders & Their Treatment. 2002;1:17–24.
  • Schmitz JM, Stotts AL, Sayre SL, et al. Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy. American Journal of Addictions. 2004;13:333–341. [PubMed]
  • Schmitz JM, Lindsay JA, Green CE, et al. High-dose naltrexone therapy for cocaine-alcohol dependence. American Journal of Addictions. 2009;18:356–362. [PMC free article] [PubMed]
  • Schuckit MA. Alcohol-use disorders. Lancet. 2009;373:492. [PubMed]
  • Schultz W. Behavioral dopamine signals. Trends in Neuroscience. 2007;30:203–210. [PubMed]
  • Schumacher L, Pruitt N II, Phillips M. Identifying patients “At Risk” of alcohol withdrawal syndrome and a treatment protocol. Journal of Neuroscience Nursing. 2000;32:158–163. [PubMed]
  • Schwab-Stone M, Shaffer D, Dulcan M, et al. Criterion validity of the NIMH Diagnostic Interview Schedule for Children version 2.3 (DISC-2.3) Journal of the American Academy of Child and Adolescent Psychiatry. 1996;35:878–888. [PubMed]
  • Schwamm LH, Van Dyke C, Kiernan RJ, et al. The Neurobehavioural Cognitive Status Examination and the Mini-Mental State Examination in a neurosurgical population. Annals of Internal Medicine. 1987;107:486–491. [PubMed]
  • Schwan R, Loiseaux MN, Schellenberg F, et al. Multicenter validation study of the %CDT TIA kit in alcohol abuse and alcohol dependence. Alcoholism: Clinical and Experimental Research. 2004;28:1331–1337. [PubMed]
  • Sellman JD, Sullivan PF, Dore GM, et al. A randomized controlled trial of motivational enhancement therapy (MET) for mild to moderate alcohol dependence. Journal of Studies on Alcohol. 2001;62:389–396. [PubMed]
  • Schaffer D, Fisher P, Dulcan M, et al. The NIMH Diagnostic Interview Schedule for Children (DISC-2): description, acceptability, prevalences, and performance in the MECA study. Journal of the American Academy of Child and Adolescent Psychiatry. 1996;35:865–877. [PubMed]
  • Sereny G, Sharma V, Holt J. Mandatory supervised Antabuse therapy in an outpatient alcoholism program: a pilot study. Alcoholism: Clinical and Experimental Research. 1986;10:290–292. [PubMed]
  • Shakeshaft AP, Bowman JA, Burrows S, et al. Community-based alcohol counselling: a randomized clinical trial. Addiction. 2002;97:1449–1463. [PubMed]
  • Shaw GK, Waller S, Latham CJ, et al. The detoxification experience of alcoholic in-patients and predictors of outcome. Alcohol & Alcoholism. 1998;33:291–303. [PubMed]
  • Shaw CM, Creed F, Tomenson B, et al. Prevalence of anxiety and depressive illness and help seeking behaviour in African Caribbeans and white Europeans: two phase general population survey. British Medical Journal. 1999;318:302–306. [PMC free article] [PubMed]
  • Shaw J, Appleby L, Baker D. Safer Prisons: A National Study of Prison Suicides 1999–2000 by the National Confidential Inquiry into Suicides and Homicides by People with Mental Illness. London: Department of Health; 2003.
  • Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM–IV and ICD–10. Journal of Clinical Psychiatry. 1998;59(Suppl. 20):22–33. [PubMed]
  • Sher L. Alcohol consumption and suicide. Quarterly Journal of Medicine. 2006;99:57–61. [PubMed]
  • Sinclair JMA, Green J. Understanding resolution of deliberate self harm: qualitative interview study of patients’ experiences. British Medical Journal. 2005;330:1112–1115. [PMC free article] [PubMed]
  • Sinclair J, Latifi AH, Latifi AW. Co-morbid substance misuse in psychiatric inpatients: prevalence and association with length of inpatient stay. Journal of Psychopharmacology. 2008;22:92–98. [PubMed]
  • Sinclair J, Hawton K, Gray A. Six year follow-up of a clinical sample of self-harm patients. Journal of Affective Disorders. 2009;121:247–252. [PubMed]
  • Singleton N, Meltzer H, Gatward R. Psychiatric Morbidity Among Prisoners in England and Wales. London: Her Majesty’s Stationery Office; 1998.
  • Sinha R, O’Malley SS. Alcohol and eating disorders: implications for alcohol treatment and health services research. Alcoholism, Clinical & Experimental Research. 2000;24:1312–1319. [PubMed]
  • Sisson RW, Azrin N. The community reinforcement approach, Handbook of Alcoholism Treatment Approaches: Effective Alternatives. Hester R, Miller WR, editors. New York, NY: Pergamon Press; 1989. pp. 242–258.
  • Sitharthan T, Sitharthan G, Hough MJ, et al. Cue exposure in moderation drinking: a comparison with cognitive-behavior therapy. Journal of Consulting and Clinical Psychology. 1997;65:878–882. [PubMed]
  • Skills for Health. Drugs and Alcohol National Occupational Standards (DANOS) Bristol: Skills for Health; 2002. [February 2011]. Available from: http://www​.skillsforhealth​​/~/media/Resource-Lbrary2​/PDF/AD%20DANOS%20guide.ashx.
  • Skinner HA, Horn JL. Alcohol Dependence Scale: Users Guide. Toronto: Addiction Research Foundation; 1984.
  • Skinner HA, Sheu WJ. Reliability of alcohol use indices: the Lifetime Drinking History and the MAST. Journal of Studies on Alcohol. 1982;43:1157–1170. [PubMed]
  • Slattery J, Chick J, Cochrane M, et al. HTA Report 3: Prevention of Relapse in Alcohol Dependence; HTA Advice 3: Prevention of Relapse in Alcohol Dependence; Understanding HTBS Advice: Prevention Of Relapse in Alcohol Dependance. Glasgow: Health Technology Board for Scotland (HTBS); 2003.
  • Small B, Vitanen M, Bachman L. Mini-Mental State Examination item scores as predictors of Alzheimer’s disease: incident data from the Kungsholmen Project, Stockholm. Journal of Gerontology. 1997;52A:M299–M304. [PubMed]
  • Smart RG, Finley J, Funston R. The effectiveness of post-detoxification referrals: effects on later detoxification admissions, drunkenness and criminality. Drug and Alcohol Dependence. 1977;2:149–155. [PubMed]
  • Smith M. The search for insight: clients’ psychological experiences of alcohol withdrawal in a voluntary, residential, health care setting. International Journal of Nursing Practice. 2004;10:80–85. [PubMed]
  • Smith I, Hillman A. Management of alcohol Korsakoff syndrome. Advances in Psychiatric Treatment. 1999;5:271–278.
  • Smith MO, Khan I. An acupuncture programme for the treatment of drug addicted persons. Bulletin and Narcotics. 1988;XL:35–41. [PubMed]
  • Smith KL, Horton NJ, Saitz R, et al. The use of the mini-mental state examination in recruitment for substance abuse research studies. Drugs and Alcohol Dependence. 2006;82:231–237. [PubMed]
  • Sobell MB, Sobell LC. Problem Drinkers: Guided Self-Change Treatment. New York, NY: Guilford Press; 1993.
  • Sobell MB, Sobell LC. Stepped care as a heuristic approach to the treatment of alcohol problems. Journal of Consulting and Clinical Psychology. 2000;68:573–579. [PubMed]
  • Sobell LC, Sobell MB. Alcohol consumption measures. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2003. [23 March 2010]. Available from: http://pubs​.niaaa.nih​.gov/publications/Assesing%20Alcohol​/sobell.pdf.
  • Sobell LC, Maisto SA, Sobell MB, et al. Reliability of alcohol abusers’ self-reports of drinking behavior. Behavior Research Therapy. 1979;17:157–160. [PubMed]
  • Sobell LC, Sobell MB, Leo GI. Does enhanced social support improve outcomes for problem drinkers in guided self-change treatment. Journal of Behavior Therapy and Experimental Psychiatry. 2000;31:41–54. [PubMed]
  • Sobell LC, Sobell MB, Leo GI, et al. Promoting self change with alcohol abusers: A community-level mail intervention based on natural recovery studies. Alcoholism: Clinical and Experimental Research. 2002;26:936–948. [PubMed]
  • South West London and St George’s Mental Health NHS Trust. The Blue Book: Guidelines for the Management of Common/Selected Psychiatric Emergencies and Certain Trust Policies and Procedures. 13. London: South West London and St Georges Mental Health NHS Trust; 2010.
  • Soyka M, Horak M. Outpatient alcohol detoxification: implementation efficacy and outcome effectiveness of a model project. European Addiction Research. 2004;10:180–187. [PubMed]
  • Spanagel R, Zieglgansberger W, Hundt W. Acamprosate and alcohol: III. Effects on alcohol discrimination in the rat. European Journal of Pharmacology. 1996;305:51–56. [PubMed]
  • Spiegelhalter DJ, Thomas A, Best NG, et al. WinBUGS User Manual: Version 1.4. Cambridge: MRC Biostatistics Unit; 2001.
  • Spreen O, Strauss E. A Compendium of Neuropsychological Tests. 2. London: Oxford University Press; 1998.
  • Srivastava A, Kahan M, Ross S. The effect of methadone maintenance treatment on alcohol consumption: a systematic review. Journal of Substance Abuse Treatment. 2008;34:215–223. [PubMed]
  • Staner L, Boeijinga P, Danel T, et al. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects. Alcoholism: Clinical and Experimental Research. 2006;30:1492–1499. [PubMed]
  • StataCorp. Stata Statistical Software: Release 10. College Station, TX: StataCorp LP; 2007.
  • Stein LI, Newton JR, Bowman RS. Duration of hospitalization for alcoholism. Archives of General Psychiatry. 1975;32:247–252. [PubMed]
  • Stiles WB, Barkham M, Twigg E, et al. Effectiveness of cognitive-behavioural, person-centred and psychodynamic therapies as practised in UK National Health Service settings. Psychological Medicine. 2006;36:555–566. [PubMed]
  • Stinnett JL. Outpatient detoxification of the alcoholic. International Journal of the Addictions. 1982;17:1031–1046. [PubMed]
  • Stinson DJ, Smith WG, Amidjaya I, et al. Systems of care and treatment outcomes for alcoholic patients. Archives of General Psychiatry. 1979;36:535–539. [PubMed]
  • Stitzer ML, Iguchi MY, Felch LJ. Contingent take-home incentive: effects on drug use of methadone maintenance patients. Journal of Consulting and Clinical Psychology. 1992;60:927–934. [PubMed]
  • Stockwell T, Hodgson R, Edwards G, et al. The development of a questionnaire to measure severity of alcohol dependence. British Journal of Addictions to Alcohol and Other Drugs. 1979;74:78–87. [PubMed]
  • Stockwell T, Murphy D, Hodgson R. The severity of alcohol dependence questionnaire: its use, reliability and validity. British Journal of Addictions. 1983;78:145–155. [PubMed]
  • Stockwell T, Bolt E, Hooper J. Detoxification from alcohol at home managed by general practitioners. British Medical Journal. 1986;292:733–735. [PMC free article] [PubMed]
  • Stockwell T, Bolt E, Milner I, et al. Home detoxification for problem drinkers: acceptability to clients, relatives, general practitioners and outcome after 60 days. British Journal of Addiction. 1990;85:61–70. [PubMed]
  • Stockwell T, Bolt L, Milner I, et al. Home detoxification from alcohol: its safety and efficacy in comparison with inpatient care. Alcohol and Alcoholism. 1991;26:645–650. [PubMed]
  • Stout R, Rubin A, Zwick W, et al. Optimizing the cost-effectiveness of alcohol -treatment: a rationale for case monitoring. Addictive Behaviours. 1999;24:17–35. [PubMed]
  • Stouthard MEA, Essink-Bot ML, Bonsel GJ, et al. Disability Weights for Diseases in the Netherlands. Rotterdam: Erasmus University; 1997.
  • Strang J, Marks I, Dawe S, et al. Type of hospital setting and treatment outcome with heroin addicts. British Journal of Psychiatry. 1997;171:335–339. [PubMed]
  • Sullivan JT, Swift RM, Lewis DC. Benzodiazepine requirements during alcohol withdrawal syndrome: clinical implications of using a standardized withdrawal scale. Journal of Clinical Psychopharmacology. 1991;11:291–295. [PubMed]
  • Sullivan JT, Sykora K, Schneiderman J, et al. Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-AR) British Journal of Addiction. 1989;84:1353–1357. [PubMed]
  • Szapocznik J, Perez-Vidal A, Brickman AL, et al. Engaging adolescent drug abusers and their families in treatment: a strategic structural systems approach. Journal of Consulting and Clinical Psychology. 1988;56:552–557. [PubMed]
  • Szapocznik J, Rio A, Murray E, et al. Structural family versus psychodynamic child therapy for problematic Hispanic boys. Journal of Consulting and Clinical Psychology. 1989;57:571–578. [PubMed]
  • Szapocznik J, Hervis O, Schwartz S. Brief strategic family therapy for adoelescent drug abuse. NIH Publication No. 03-4751, NIDA Therapy Manuals for Drug Addiction. Rockville, MD: National Institute on drug abuse; 2003.
  • Tabakoff B, Cornell N, Hoffman PL. Alcohol tolerance. Annals of Emergency Medicine. 1986;15:1005–1012. [PubMed]
  • Teasdale JD, Segal Z, Williams JMG. How does cognitive therapy prevent depressive relapse and why should control (mindfulness) training help? Behaviour Research and Therapy. 1995;33:25–39. [PubMed]
  • Tempesta E, Janiri L, Bignamini A, et al. Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study. Alcohol and Alcoholism. 2000;35:202–209. [PubMed]
  • The NHS Information Centre, Lifestyles Statistics. Statistics on Alcohol: England, 2009. The NHS Information Centre for health and social care; 2009. [31 March 2011]. Available from: http://www​​/webfiles/publications​/alcoholeng2009/Final​%20Format%20draft%202009%20v7.pdf.
  • Thevos AK, Thomas SE, Randall KL. Baseline differences in social support among treatment-seeking alcoholics with and without social phobia. Substance Abuse. 1999;20:1573–6733. [PubMed]
  • Thom B, Green A. Services for women with alcohol problems: the way forward, Alcohol Problems in the Community. Harrison L, editor. London: Routledge; 1996. pp. 200–222.
  • Thomas BA, McCambridge J. Comparative psychometric study of a range of hazardous drinking measures administered online in a youth population. Drug and Alcohol Dependence. 2008;96:121–127. [PubMed]
  • Thomson AD, Cook CCH. Parenteral thiamine and Wernicke’s encephalopathy: the balance of risks and perception of concern. Alcohol and Alcoholism. 1997;32:207–209. [PubMed]
  • Thomson AD, Marshall EJ. The treatment of patients at risk of developing Wernicke’s encephalopathy in the community. Alcohol and Alcoholism. 2006;41:159–167. [PubMed]
  • Thomson AD, Jeuasingham M, Pratt OE. Nutrition and alcoholic encephalopathies. Acta Medica Scandinavica. 1987;717:55–65. [PubMed]
  • Thompson KS, Griffith EEH, Leaf PJ. A historical review of the Madison Model of community care. Hospital and Community Psychiatry. 1990;41:625–634. [PubMed]
  • Timko C, DeBenedetti A. A randomized controlled trial of intensive referral to 12-step self-help groups: one year outcomes. Drug and Alcohol Dependence. 2007;90:270–279. [PubMed]
  • Tober G, Godfrey C, Parrott S, et al. Setting standards for training and competence: the UK Alcohol Treatment Trial. Alcohol & Alcoholism. 2005;40:413–418. [PubMed]
  • Tober GW, Brearley R, Kenyon R, et al. Measuring outcomes in a health service addiction clinic. Addiction Research. 2000;8:169–182.
  • Tonigan JS, Miller WR, Brown JM. The reliability of Form 90: an instrument for assessing alcohol treatment outcome. Journal of Studies on Alcohol. 1997;88:358–364. [PubMed]
  • Tonigan JS, Connors GJ, Miller WR. Participation and involvement in Alcoholics Anonymous, Treatment Matching in Alcoholism. Babor TF, Del Boca FK, editors. New York, NY: Cambridge University Press; 2003. pp. 184–204.
  • Torrens M, Fonseca F, Mateu G, et al. Efficacy of antidepressants in substance use disorders with and without comorbid depression: a systematic review and meta-analysis. Drug and Alcohol DependenceDrug and Alcohol Dependence. 2005;78:1–22. [PubMed]
  • Trepka C, Rees A, Shapiro DA, et al. Therapist competence and outcome of cognitive therapy for depression. Cognitive Therapy & Research. 2004;28:143–157.
  • Tripodi SJ, Bender K, Litschge C, et al. Interventions for reducing adolescent alcohol abuse: a meta-analytic review. Archives of Pediatrics & Adolescent Medicine. 2010;164:85–91. [PubMed]
  • UKATT Research Team. Effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT) British Medical Journal. 2005;331:541–545. [PMC free article] [PubMed]
  • UKATT Research Team. UK alcohol treatment trial: client-treatment matching effects. Addiction. 2007;103:228–238. [PubMed]
  • United Nations. Convention on Psychotropic Substances, 1971. New York: United Nations; 1977.
  • Upadhyaya HP. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder. The Journal of Clinical Psychiatry. 2007;68(Suppl. 11):23–30. [PubMed]
  • Ugarte G, Iturriaga H, Pereda T. Possible relationship between the rate of ethanol metabolism and the severity of hepatic damage in chronic alcoholics. American Journal of Digestive Diseases. 1977;22:406–410. [PubMed]
  • Vandermause R, Wood M. See my suffering: women with alcohol use disorders and their primary care experiences. Issues in Mental Health Nursing. 2009;30:728–735. [PubMed]
  • Vandermause RK. Assessing for alcohol use disorders in women: experiences of advanced practice nurses in primary care settings. Journal of Addictions Nursing. 2007;18:187–198.
  • Vandevelde S, Vanderplasschen W, Broekaert E, et al. Cultural responsiveness in substance-abuse treatment: a qualitative study using professionals’ and clients’ perspectives. International Journal of Social Welfare. 2003;12:221–228.
  • Vargas D, Luis MAV. Alcohol, alcoholism and alcohol addicts: conceptions and attitudes of nurses from district basic health centres. Revista Latino-Americana de Enfermagem. 2008;16:543–550. [PubMed]
  • Vedel E, Emmelkamp PMG, Schippers GM. Individual cognitive-behavioral therapy and behavioural couples therapy in alcohol use disorder: a comparative evaluation in community-based addiction treatment centres. Psychotherapy and Psychosomatics. 2008;77:280–288. [PubMed]
  • Verheul R, van den Brink W, Hartgers C. Personality disorders predict relapse in alcoholic patients. Addictive Behaviours. 1998;23:869–882. [PubMed]
  • Verheul R, Lehert P, Geerlings PJ, et al. Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients. Psychopharmacology. 2005;178:2–3. [PubMed]
  • Victor M, Adams RD, Collins GH. The Wernicke-Korsakoff Syndrome. Philadelphia, PA: F. A. Davis Company; 1971.
  • Victor M, Adams RD, Collins GH. The Wernicke-Korsakoff Syndrome and Related Neurological Disorders Due to Alcoholism and Malnutrition. Philadelphia, PA: F. A. Davis Company; 1989.
  • Villardita C, Lomeo C. Alzheimer’s disease: Correlational analysis of three screening tests and three behavioural scales. Acta Neurologica Scandinavica. 1992;86:603–608. [PubMed]
  • Volpicelli JR, Alterman AI, Hayashida M, et al. Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry. 1992;49:876–880. [PubMed]
  • Volpicelli JR, Rhines KC, Rhines JS, et al. Naltrexone and alcohol dependence: role of subject compliance. Archives of General Psychiatry. 1997;54:737–742. [PubMed]
  • Waldron HB, Kaminer Y. On the learning curve: the emerging evidence supporting cognitive-behavioral therapies for adolescent substance abuse. Addiction. 2004;99(Suppl. 2):93–105. [PMC free article] [PubMed]
  • Waldron HB, Slesnick N, Brody JL, et al. Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. Journal of Consulting and Clinical Psychology. 2001;69:802–813. [PubMed]
  • Walitzer KS, Connors GJ. Thirty month follow-up of drinking moderation training for women: A randomized clinical trial. Journal of Consulting and Clinical Psychology. 2007;75:501–507. [PubMed]
  • Walitzer KS, Dermen KH. Alcohol-focused spouse involvement and behavioural couples therapy: evaluation of enhancements to drinking reduction treatment for male problem drinkers. Journal of Consulting and Clinical Psychology. 2004;72:944–955. [PubMed]
  • Walitzer KS, Dermen KH, Barrick C. Facilitating involvement in Alcoholics Anonymous during out-patient treatment: a randomized clinical trial. Addiction. 2009;104:391–401. [PMC free article] [PubMed]
  • Walsh DC, Hingson RW, Merrigan DM, et al. A randomized trial of treatment options for alcohol-abusing workers. The New England Journal of Medicine. 1991;325:775–782. [PubMed]
  • Walters D, Connors JP, Feeney FX, et al. The cost effectiveness of naltrexone added to cognitive-behavioral therapy in the treatment of alcohol dependence. Journal of Addictive Diseases. 2009;28:137–144. [PubMed]
  • Walters GD. The heritability of alcohol abuse and dependence: a meta-analysis of behavior genetic research. American Journal of Drug and Alcohol Abuse. 2002;28:557–584. [PubMed]
  • Wasilewski D, Matsumoto H, Kur E, et al. Assessment of diazepam loading dose therapy of delirium tremens. Alcohol and Alcoholism. 1996;31:273–278. [PubMed]
  • Watkins KE, Paddock SM, Zhang L, et al. Improving care for depression in patients with comorbid substance misuse. American Journal of Psychiatry. 2006;163:125–132. [PubMed]
  • Weaver MF, Hoffman HJ, Johnson RE, et al. Alcohol withdrawal pharmacotherapy for inpatients with medical comorbidity. Journal of Addictive Diseases. 2006;25:17–24. [PubMed]
  • Weaver T, Madden P, Charles V, et al. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. British Journal of Psychiatry. 2003;183:304–313. [PubMed]
  • Wechsler D. Wechsler Memory Scale: Third Edition (WMS-III) San Antonio: Harcourt Assessment; 1945/1997.
  • Wechsler D. Manual for the Wechsler Adult Intelligence Scale—Revised. New York, NY: Psychological Corporation; 1981.
  • Weithmann G, Hoffmann M. A randomised clinical trial of inpatient versus combined day hospital treatment of alcoholism: primary and secondary outcome measures. European Addiction Research. 2005;11:197–203. [PubMed]
  • Webb M, Unwin A. The outcome of outpatient withdrawal from alcohol. British Journal of Addiction. 1988;83:929–934. [PubMed]
  • Weisner C, Ray GT, Mertens JR, et al. Short-term alcohol and drug treatment outcomes predict long-term outcome. Drug & Alcohol Dependence. 2003;71:281–294. [PubMed]
  • Weiss RD. Inpatient treatment, Textbook of Substance Abuse Treatment. Galanter M, Kleber HD, editors. Washington, DC: The American Psychiatric Press; 1999.
  • Weiss RD, Griffin ML, Kolodzeij ME, et al. A randomised trial of integrated group therapy versus group drug counselling for patients with bipolar disorder and substance dependence. American Journal of Psychiatry. 2007;164:100–107. [PubMed]
  • Wen HL. Acupuncture and electrical stimulation (AES) outpatient detoxification. Modern Medicine. 1979;11:23–24.
  • Wen HL, Cheung SY. Treatment of drug addiction by acupuncture and electrical stimulation. Asian Journal of Medicine. 1973;9:138–141.
  • Wetterling T, Kanitz RD, Besters B, et al. A new rating scale for the assessment of the alcohol withdrawal syndrome (AWS scale) Alcohol and Alcoholism. 1997;32:753–760. [PubMed]
  • White HR, Labouvie EW. Towards the assessment of adolescent problem drinking. Journal of Studies on Alcohol. 1989;50:30–37. [PubMed]
  • White AR, Rampes H, Campbell JL. Acupuncture and related interventions for smoking cessation. Cochrane Database Systematic Review. 2006:CD000009. [PubMed]
  • Whitfield C. Non-drug treatment of alcohol withdrawal. Current Psychiatric Therapy. 1980;19:101–109. [PubMed]
  • Whitworth AB, Fischer F, Lesch OM, et al. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. The Lancet. 1996;347:1438–1442. [PubMed]
  • WHO. The International Classification of Diseases: Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. 10. Geneva: WHO; 1992.
  • WHO. International Guide for Monitoring Alcohol Consumption and Related Harm. Geneva: WHO; 2000.
  • WHO. Global Status Report on Alcohol 2004. Geneva: WHO; 2004.
  • WHO. Lexicon of Alcohol and Drug Terms Published by the World Health Organization. Geneva: WHO; 2010.
  • WHO. Screening and Brief Intervention for Alcohol Problems in Primary Health Care. Geneva: WHO; 2010.
  • Wilcox HC, Conner KR, Caine ED. Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies. Drug & Alcohol Dependence. 2004;76:S11–S19. [PubMed]
  • Wilens TE, Adler LA, Weiss MD, et al. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug & Alcohol Dependence. 2008;96:145–154. [PubMed]
  • Willems PJA, Letemendia FJJ, Arroyave F. A categorization for the assessment of prognosis and outcome in the treatment of alcoholism. The British Journal of Psychiatry. 1973;122:649–654. [PubMed]
  • Williams BTR, Drummond DC. The Alcohol Problems Questionnaire: reliability and validity. Drug & Alcohol Dependence. 1994;35:239–343. [PubMed]
  • Winters K, Henly G. Adolescent Diagnostic Interview (ADI) Manual. Los Angeles, CA: Western Psychological Services; 1993.
  • Winters K, Stinchfield R, Fulkerson J, et al. Measuring alcohol and cannabis use disorders in an adolescent clinical sample. Psychology of Addictive Behaviors. 1993;7:185–196.
  • Winters KC, Henly GA. Personal Experience Inventory (PEI) Test and Manual. Los Angeles, CA: Western Psychological Services; 1989.
  • Winters KC, Stinchfield R, Opland E, et al. The effectiveness of the Minnesota Model approach to the treatment of adolescent drugs abusers. Addiction. 2000;95:601–612. [PubMed]
  • Winters L, McGourty H. Alcohol Services in Chester and Ellesmere Port. Liverpool: Liverpool Public Health Observatory; 1994. (Observatory Report Series No. 22).
  • Wiseman EJ, Henderson KL, Briggs MJ. Outcomes of patients in a VA ambulatory detoxification program. Psychiatric Services. 1997;48:200–203. [PubMed]
  • Witbrodt J, Bond J, Kaskutas LA, et al. Day hospital and residential addiction treatment: Randomized and nonrandomized managed care clients. Journal of Consulting and Clinical Psychology. 2007;75:947–959. [PubMed]
  • Woody GE. Research findings on psychotherapy of addictive disorders. American Journal on Addictions. 2003;12(Suppl. 2):S19–S26. [PubMed]
  • Worner TM, Zeller B, Schwarz H, et al. Acupuncture fails to improve treatment outcome in alcoholics. Drug and Alcohol Dependence. 1992;30:169–173. [PubMed]
  • Wu LT, Ringwalt CL. Alcohol dependence and use of treatment services among women in the community. American Journal of Psychiatry. 2004;161:1790–1797. [PMC free article] [PubMed]
  • Velleman R, Orford J. Risk & Resilience: Adults who were the Children of Problem Drinkers. London: Harwood; 1999.
  • Xin X, He J, Frontini MG, et al. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2001;38:1112–1117. [PubMed]
  • Yeh MY, Che HL, Wu SM. An ongoing process: a qualitative study of how the alcohol-dependent free themselves of addiction through progressive abstinence. BMC Psychiatry. 2009;9:76. [PMC free article] [PubMed]
  • Yoon SJ, Pae CU, Namkoong K, et al. Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: a multicentre, open label study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2006;30:1196–1201. [PubMed]
  • Yoshida K, Funahashi M, Masui M, et al. Sudden death of alcohol withdrawal syndrome – a report of a case. Japanese Journal of Legal Medicine. 1990;44:243–247. [PubMed]
  • Zahl D, Hawton K. Repetition of deliberate self harm and subsequent suicide risk: long term follow up study of 11583 patients. British Journal of Psychiatry. 2004;185:70–75. [PubMed]
  • Zarkin GA, Bray JW, Aldridge A, et al. Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients. Archives of General Psychiatry. 2008;65:1214–1221. [PMC free article] [PubMed]
  • Zeigler D, Wang C, Yoast R, et al. The neurocognitive effects of alcohol on adolescents and college students. Preventive Medicine. 2005;40:23–32. [PubMed]
  • Zemore SE, Kaskutas LA. Services received and treatment outcomes in day-hospital and residential programs. Journal of Substance Abuse Treatment. 2008;35:232–44. [PMC free article] [PubMed]
  • Zgierska A, Rabago D, Zuelsdorff M, et al. Mindfulness meditation for alcohol relapse prevention: a feasibility pilot study. Journal of Addiction Medicine. 2008;2:165–173. [PMC free article] [PubMed]
  • Zweben A, Pearlman S, Li S. A comparison of brief advice and conjoint therapy in the treatment of alcohol abuse: the results of the marital systems study. British Journal of Addiction. 1988;83:899–916. [PubMed]

Alcohol AUDIT Tool

SAMSHA Detoxification in substance Abuse Tip 45

Online practitioners guide to alcohol abuse


Medication Management Support for Alcohol Dependence

Alcohol Baseline Progress Note

Questions of Alcohol assessment

SBIRT – screening and brief interventions

Alcohol Screening SBIRT pocket guide

college drinking supplement

Links to professional manuals on line

Addiction Severity Index:  Structured interview for assessment of addiction:

Addiction Severity Index from europen eu


Kentucky Court ASI

ADDICTION severity index Lite


Addiction Severity Index – assessment tool for addiction PDF

Structured Clinical INterviews for DSM-4:

SCID – Structured Clinical Interview for DSM-IV  < links to handouts

SCID Module_E_Substance_Use_Disorders-Standard_Version

SCID Module_E_Substance_Use_Disorders-Alternate_Version

SCID module_alt_e_comprehensive

SCID module_e_streamlined

SCID Module_F_Anxiety_Disorders

Mini International Neuropsychiatric Interview (MINI)

Mini International Neuropsychiatric Interview (MINI)

Composite International Diagnostic Interview-Substance Abuse Module

ADAI Library link’

Assessing Addiction Concepts and Instruments

Structure, Content and Reliability of of M-CIDI substance use scoring


Adolescent ScreeningInstruments Compendium

CAGE_questionaire Disease staging tool Alcoholism

CAGE Substance Screening Tool

Management of  Substance abuse disorders – clinical guidelines

Functional analysis and treatment planning alcoholism

Substance abuse outcomes scales

Intoxication and Withdrawal Assessment

Alcohol Withdrawal Assessment Scoring Guidelines (CIWA – Ar)

Clinical Institute Withdrawal Assessment of Alcohol Scale, Revised (CIWA-Ar) North carolina pregnancy and opioid project

COWS scale

Assessment of Comorbid Conditions:

Link to PHQ screeners

PHQ-9_English  < Depression screening


On line PHQ 9


Beck anxiety scale

Beck-Anxiety-Inventory scale

South oaks gambling screen < Gambling Addiction

Drinkers inventory of consequences  < Consequences of drinking – self-reported

Inventory of Drug use consequences – link

Inventory of Drug use consequences motivational interviewing page link

The Stages of Change Readiness and Treatment Eagerness Scale  < Change readiness


SOCRATESv8 – stages of change Readiness PDF

Initial adult substance abuse assessment

DrugFree World Downloads

L3C05-RiskSit-S Inventory of Drug USe

Inventory of Drug-Taking Situations (IDTS-8)


Triggers, coping mechanisms, self-efficacy, confidence, expectations, – self reporting instruments:

Brief Situational Confidence Questionnaire

Brief Situational Confidence Questionnaire (BSCQ)


Coping Responses Inventory  – assess avoidant coping and approach coping – 48 items

Drug – alcohol taking confidence questionaaire – self efficacy measure

Alcohol expectancy Questionnaire < Expectations from alcohol

Short Inventory of Problems FU < Measures physical, social, interpersonal, impulsive, and intrapersonal consequences of alcohol and drug consumption

Short inventory of problems  < clinical trials dissemination Library

NIAAA clinical guidelines and training  < clinical guidelines – training- manuals

Alcohol model for decreasing injury and death

Methamphetamine logic model for decreasing Abuse





Ketamine Treatment Center | 703-844-0184 | Ketamine Doctor | IV Vitamin Therapy | Vitamin Drip | Vitamin Doctor | IV NAD Therapy | Intranasal Ketamine | Ketamine for Depression Pain PTSD | IV Ketamine | Addiction Treatment Center |Suboxone | Sublocade |Vivitrol | Alcohol Treatment Center | Fairfax, Va | Addiction doctors| CBD Doctor | CBD Treatment Center | Neograft | Hair Transplantation | Hair Restoration Center | Optifast | Weight Loss Center | Medical Weight Loss | Alexandria | Springfield, Va | 22306 | 22314 | 22030 | 22304 | 22036 | 22037 | 22038 | 20598 | Low Dose Naltrexone | LDN